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1. Enantioselective Pd(II)-Catalysed Nucleophilic Additions of 2-
Alkylazaarenes 
The first project deals with enantio- and diastereoselective palladium(II)-catalysed 
nucleophilic additions of 2-alkylazaarenes to N-Boc imines and nitroalkenes. Under 
the optimised reaction conditions high levels of diastereo- and enantioselection of the 
addition products were achieved. Introduction of the electron-withdrawing group at 
the aryl ring of the substrate allows running the reaction under mild, experimentally 
convenient reaction conditions. The new described method allows the 
enantioselective synthesis of 2-(β-aminoalkyl)azaarenes, which are substructures 
found in drug candidates molecules for the treatment of type 2 diabetes and 
schizophrenia.  
  
2. Synthesis of Spirocyclic Enones via Rh(III)-Catalysed C–H 
Functionalisation  
The second project describes the synthesis of spirocyclic enones by rhodium(III)-
catalysed dearomatising oxidative annulation of 2-alkenylphenols with alkynes and 
1,3-enynes. A good to high yield with great regioselectivity was obtained. The 
further synthetic utility of the product was also investigated and led to the formation 
of highly functionalised tetracycles via 1,6 conjugation addition reaction. 
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1. ENANTIOSELECTIVE PD-CATALYSED NUCLEOPHILIC 
ADDITIONS OF 2-ALKYLAZAARENES TO N-BOC IMINES 
AND NITROALKENES  
1.1 INTRODUCTION 
Heteroarenes are important chemical motifs which are present in many natural 
products, agrochemicals or industry due to their physical, chemical and biological 
properties.
[1],[2]
 They are often used as building blocks for the development of new 




Figure 1.1: Natural products and drugs containing heterocycles.  
Synthetic methods that enable functionalisation of azaarenes and their derivatives 
such as cross-coupling reactions, direct arylation, electrophilic and nucleophilic 
substitution (Scheme 1.1),
[6],[7]
 are very useful for generating new C–C bonds. 
Addition reactions of electron-rich azaarenes containing an embedded enamine 
moiety, such as indoles and pyrroles, to π-electrophiles have been extensively studied 
and can provide the addition product in an enantioselective fashion (e.g. Friedel-
Crafts alkylation).
[8]
 However, with regards to asymmetric functionalisation of 
electron- poor azaarenes with an imine-embedded motif, the existing methodologies 
provide the product in good yield but chirality is often not generated. Therefore, the 
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Scheme 1.1: Existing synthetic methodologies. 
This part of the thesis will be focused on asymmetric addition reactions of various 
nucleophiles to alkenylazaarenes. Recent studies towards activation of 
alkylazaarenes in nucleophilic additions reactions to π-deficient electrophiles which 
delivered enantio- and diasteroselective products will be described. Presented 
examples describing the mode of activation by azaaarenes in asymmetric catalysis 
are based on the work done within our group,
[9]
 supported with a brief overview of 
existing literature. 
1.1.1 CATALYTIC ENANTIOSELECTIVE NUCLEOPHILIC ADDITIONS TO 
2-ALKENYLAZAARENES 
One of the fundamental C–H/C–C bond forming reactions is the transition-metal 
catalysed 1,4-addition of a nucleophile to an alkene activated by an adjacent 
electron-withdrawing group (Scheme 1.2A). As this type of reaction has been widely 
studied racemically and enantioselectively to synthesise molecules of interest,
[10]
 our 
group questioned whether having a C=N moiety of a heteroarene adjacent to an 
alkene could provide similar effective activation towards nucleophilic attack for 
asymmetric conjugate addition reactions (Scheme 1.2B). In other words, can the 
C=N moiety act as a carbonyl equivalent? If the answer to this question is yes, then, 
the addition of the nucleophile could proceed via temporary loss of aromaticity. 
Finding the catalytic system which could provide this challenging mode of activity 
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Scheme 1.2: Conjugate addition reactions. 
Based on well-established copper hydride reductions
[11],[12]
 of various activated 
alkenes, α,β-unsaturated carbonyl compounds, nitriles, sulfones, phosphonates and 
nitro compounds, interest in β,β-disubstituted alkenylazaarenes as conjugate 
reductive substrates arose in the Lam group. It was hoped that the embedded C=N 
moiety of an azaarene adjacent to an alkene would be sufficiently activating for this 
sterically hindered starting material to form a new C–H bond in an enantioselective 
fashion. By treating 2-alkenylazaarenes 1.1 with a chiral copper-hydride catalyst, the 
group demonstrated an effective method for highly enantioselective catalytic 1,4-
reduction of these compounds (Scheme 1.3).
[13]
 The reaction is generally applicable 
for azaarenes such as (benz)oxazoles (1.2a and 1.2b), benzothiazole (1.2c), pyridine 
(1.2d), quinoline (1.2e), and pyrazine 1.2f). Moreover, the incorporation of various 
functional groups, such as esters (1.2d), cyclopropanes (1.2e), and silyl ethers (1.2f) 
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Scheme 1.3: Enantioselective Cu–H conjugate reduction of various β,β-disubstituted 2- 
                          alkenylazaarenes.
[13]
 
In order to explain and understand the success of this reaction, some control 
experiments were conducted with regards to 3-alkenyl- 1.1g and 4-alkenylpyridine 
1.1h. Conjugation of the alkene with the C=N moiety is necessary for the reaction to 
occur, however the nitrogen does not have to be directly adjacent to the alkene 
moiety (Scheme 1.4). The reduction of 3-alkenylpyridine 1.1g failed under the 
optimised conditions, whereas 4-alkenylpyridine 1.1h gave the desired product in 
good yield and high enantioselectivity (Scheme 1.4).  
 
Scheme 1.4: Control experiment showing the necessity of conjugation of the alkene to a  
                          C=N moiety.
[13]
  
Following this work on copper-catalysed 1,4-reduction, the group of Yun and co-
workers investigated the reaction of 2-vinylboronate benzoxazole 1.1i (Scheme 
1.5).
[14]
 Under Lam’s reported conditions
[13]
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boronic ester 1.2i in 98% ee. Changing the reaction conditions from PhSiH3 in 
toluene to polymethylhydrosiloxane (PMHS) in THF resulted in slightly higher yield 
88% but the enantioselectivity dropped to 96%.  
 
Scheme 1.5: Enantioselective Cu–H reduction of 2-vinylboronate benzoxazole 1.1i.
[14]
 
To conclude, the copper-catalysed 1,4-reduction of β,β-disubstituted alkenylazarenes 
is an excellent way of delivering chiral alkylazaarenes enantioselectively. However, 
the possibility to form a new C–C bond via nucleophilic addition of a carbon 
nucleophile to β-monosubstituted alkenylazarenes would be more suited for the 
convergent synthesis of compound libraries. 
In 1933, the group of Hoffman, Farlow and Fuson showed that stoichiometric 
amounts of Grignard reagents can be successfully added to 2-[(E)-2-




In 1998, Houpis and co-workers presented the first catalytic addition of aryl and 
vinyl Grignard reagents and zincates to β-substituted 4-vinylpyridines 1.3. The 
racemic addition products 1.4 were obtained in good to high yields (Scheme 1.6).
[16]
 
Studies involving the effect of temperature on the process showed that it was 
necessary to heat the reaction to 45 °C directly after the Grignard addition to reduce 
formation of a biphenyl by-product and symmetrical dimers. Similar yields were 
obtained with phenyl zincate reagent (PhZnMe2MgCl) with even less formation of 
biphenyl by-product. Unfortunately, efforts towards developing an enantioselective 
variant of this reaction did not succeed. After intensive screening of various classes 
of chiral ligands such as diamines, bisphosphines, bis-sulfonamides, aminoalcohols 
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Scheme 1.6: Additions of organometallic reagents to 4-vinylpyridines 1.3 catalysed by Ni- 
                       complexes.
[16]
 
The Rh-catalysed 1,4-nuclophilic addition to activated alkenes is well developed and 
commonly used in organic synthesis. In 2001 Lautens and co-workers described the 
first rhodium-catalysed addition of boronic acids 1.5 to vinylazaarenes 1.6 under 
aqueous conditions (Scheme 1.7).
[17]
 The combination of a water-soluble phosphine 
ligand TPPDS L1.2 and [Rh(cod)Cl]2 was crucial for the reaction to succeed. In 
organic solvents the conversion was less than 10%. The addition of sodium dodecyl 
sulfate (SDS) was required to supress protodeboronation of the aryl boronic acid and 
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Scheme 1.7: Addition of aryl boronic acids 1.5 to vinylazines 1.6 under rhodium  
                               catalysis.
[17]
  
Compared to vinylazaarenes, this process is more challenging for β-substituted 
alkenylazaarenes. Introduction of an additional substituent decreases the reactivity of 
an alkene due to steric hindrance but if the reaction works, formation of a chiral 
product may be achieved. This approach was described by the Lam group and co-
workers in 2010. They found that by employing chiral diene L1.3 (6 mol%) and 
[Rh(C2H4)Cl2]2 (2 mol%), highly enantioselective additions of arylboronic acids 1.5 
to β-monosubstituted alkenylazaarene 1.8 were possible (Scheme 1.8).
[18]
 The 
reaction was promoted by microwave irradiation in 9:1 dioxane/H2O in the presence 
of KOH, which was crucial for improving the conversion. In terms of substrate 
scope, various arylboronic acids were tolerated (including methyl, chloro, isopropyl 
substituents at the phenyl ring). Various activating groups were also effective such as 
quinoline (1.9a), quinoxaline (1.9b), pyrimidine (1.9c), benzoxazole (1.9d), 
diphenyloxazole (1.9e), and oxadiazole (1.9f) in delivering the product in good to 
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Scheme 1.8: Enantioselective Rh-catalysed arylation of β-monosubstituted  
                                    alkenylazaarenes.[18] 
The proposed catalytic cycle for this process is based on Hayashi’s studies on the 
conjugate addition of arylboronic acids to enones.
[19]
 For the mechanistic 
explanation, an illustrative example of 2-alkenylpyrimidine 1.8g is presented in 
Scheme 1.9. The chiral diene-ligated rhodium hydroxide 1.10 is formed in the first 
step, which then undergoes transmetallation with arylboronic acid to generate 
rhodium aryl species 1.11. The rhodium-aryl linkage is positioned trans to the more 
electron-deficient alkene. Coordination of the alkenylazaarene 1.8g to the binding 
site of the rhodium-aryl species 1.11 occurs as depicted in 1.12 to minimise 
unfavourable non-bonding interactions between the heteroarene and the amide 
substituent of the ligand. Arylrhodation of the bound substrate results in the 
formation of aza--allylrhodium intermediate 1.13, which then undergoes hydrolysis 
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Scheme 1.9: Proposed mechanism of rhodium-catalysed conjugate addition of 
            arylboronic acids to β-monosubstituted alkenylazaarenes
[18]
 
When the reaction of 2-vinylpyridine was performed, a complex mixture of by-
products was obtained. However, further studies within our group showed that the 
introduction of a strongly electron-withdrawing nitro group at the 5 position of the 2-
alkenylpyridine 1.14 increases the reactivity dramatically, allowing 1,4-arylation of 
these type of compounds.
[20]
 Good yield and enantioselectivity was obtained when 
the combination of [(Rh(C2H4)2Cl2)]2 (2.5 mol%) and chiral ligand L1.4 (6 mol%) 
was used (Scheme 1.10).  
 
Scheme 1.10: Arylation of 5-nitro-2-alkenylazaarene 1.14 under rhodium catalysis.
[20]
  
Attempts to broaden the reaction scope and alkenylate β-monosubstituted azaarenes 
using boronic acids failed due to their instability and formation of protodeboronated 
by-products. One way to overcome this problem is to use alkenyl MIDA boronates 
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release the boronic acid in situ under controlled aqueous basic conditions to prevent 
decomposition pathways. Rhodium-catalysed reaction of alkenylquinoxaline 1.16 
and (E)-2-phenylvinyl MIDA boronate 1.17 in 5:1 dioxane/H2O in the presence of 
K2CO3 (2.0 equiv.) at 60 °C for 16 h gave the alkenylated product 1.18 in 58% yield 
and 61% ee (Scheme 1.11). 
 
Scheme 1.11: Alkenylation of alkenylquinoxaline 1.16 with MIDA boronate 1.17.
[20]
 
Simultaneously, the group of Yorimitsu and Oshima published their work on cobalt-
catalysed addition of styrylorganoboron reagents to vinylpyridines.
[21]
 One of the 
racemic examples presented in their studies is the reaction of 2-[(1E)-1-
propenyl]pyridine 1.19 with (E)-2-phenylethenylboronic acid 1.5b to give the 
addition product 1.20 in 66% yield (Scheme 1.12). 
 
Scheme 1.12: Alkenylation of propenylpyridine 1.19 under cobalt catalysis.
[21]
 
The Lam group has recently shown that a second-generation chiral diene ligand 
L1.5,
[22]
 containing a 2,4,6-triisopropylanilide moiety, gives superior results 
compared with previously described ligand L1.3 in arylation processes with 2-
alkenylazaarenes 1.8.
[18]
 Furthermore, the synthesis of the ligand L1.5 is simpler than 
of ligand L1.3 as its structure is less complex. The results of addition products with 
the two different ligands are summarised in Scheme 1.13. In general, higher 
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arylation of 2-alkenylazaarenes proceeded smoothly with a range of arylboronic 
acids 1.5. The reaction was also efficient for various activating groups such as 
quinolines (1.9a), (benz)oxazoles (1.9f and 1.9i), pyrimidines (1.9h and 1.9j), or 
triazoles (1.9k). 
 
Scheme 1.13: Comparison of ligand L1.5 with L1.3 in enantioselective arylation reactions of  
                       β-monosubstituted alkenylazaarenes 1.8 and boronic acids 1.5.
[22]
 
In 2013, Lautens and co-workers published the synthesis of aza-
dihydrodibenzoxepine 1.23 via a two-step domino reaction strategy, involving a Rh-
catalysed arylation of β-monosubstituted vinylpyridines 1.21, followed by a Pd-
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Scheme 1.14: Synthesis of aza-dihydrodibenzoxepines 1.23 using an enantioselective  
                             domino process.
[23]
 
Organocatalytic reactions have also been explored for asymmetric nucleophilic 
additions to 2-alkenylazaarenes. This type of conjugate addition reaction was 
published by the groups of Bernardi and Adamo in 2009. They showed that 
nitromethane 1.25 can be successfully added to 5-styrylisoxazoles 1.24 under chiral 
phase-transfer catalysis 1.26 (Scheme 1.15).
[24]
 Substituents containing various 
functional groups such as chloro or methoxy at the aromatic ring were tolerated and 
gave compounds 1.27b and 1.27c with 94% ee and 96% ee, respectively. Further 
investigation revealed that this process was also efficient with heteroaryl substituents 
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Scheme 1.15: Enantioselective conjugate additions of nitromethane 1.25 to 5- 
                                    styryloisoxazole 1.24.
[24]
 
This methodology provided a range of very interesting Michael addition products 
which could be functionalised further to give γ-nitrocarboxylic acid 1.28 or ester 
1.31 (Scheme 1.16). The isoxazole ring opening of product 1.28 was achieved under 
basic conditions (1 M NaOH) to provide the carboxylic acid 1.29. Similarly, the 
addition product 1.30 was functionalised to give the acid derivative which was 
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Scheme 1.16: Further product manipulation by isoxazole ring opening under basic  
                                conditions.
[24]
 
Further studies by the group of Sun and co-workers, regarding 3-methyl-4-nitro-5-
alkenylisoxazoles 1.24 as cinnamate equivalents, revealed that in the presence of 
chiral thiourea catalyst 1.33, anthrone 1.32 can be enantioselectively added to 1.24 to 
give complex products 1.34 (Scheme 1.17).
[25]
 Various substituents were tolerated at 
the alkenyl position of the isoxazole such as phenyl 1.34a, meta-chloro 1.34b, 
heteroaryl 1.34c and cyclopropanyl 1.34d giving the Michael product with good to 
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Scheme 1.17: Enantioselective addition of 3-methyl-4-nitro-5-alkenylisoxazoles 1.24 to 
                            anthrone 1.32 using thiourea catalyst 1.33.
[25]
 
Dual reactivity of the thiourea-tertiary amine catalyst is believed to be responsible 
for the success of this reaction. The activation of a nucleophile (anthrone 1.32) 
happens through the deprotonation by the basic residue of the catalyst. 
Simultaneously, the thiourea moiety is responsible for the activation of the 
electrophile (5-styrylisoxazole 1.24) via double-hydrogen bonding with the nitro 
group (Scheme 1.18). 
 
Scheme 1.18: Proposed transition state for the enantioselective 1,6-Michael addition of 5- 
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In summary, a number of transition-metal catalysed and organocatalytic reactions in 
which 2-alkenylazaarenes act as electrophiles have been developed in recent years. 
As described in this section the embedded C=N moiety may act in a similar way to a 
carbonyl group in facilitating 1,4-addition reactions. The substrate scope is quite 
broad as includes vinyl, β-mono- and β,β-disubstituted alkenyazaarenes. 
1.1.2 2-ALKYLAZAARENES AS PRONUCLEOPHILES IN C-C BOND 
FORMING REACTIONS 
As demonstrated in the first part of the introduction, azaarenes play an important role 
as activating groups for alkenes towards nucleophilic addition. In 2011, we became 
interested in 2-alkylazaarenes as potential pronucleophiles in C–C bond forming 
reactions. We wondered if the embedded C=N moiety could act similarly to a 
carbonyl group and acidify the α-proton to form an azaallyl anion. Introduction of an 
electrophile would provide an addition product via C–C bond formation (Scheme 
1.19). In other words, can an azaenolate anion act as an enolate equivalent in 
nuclophilic addition reactions? 
 
Scheme 1.19: 2-Alkenylazaarenes as pronucleophiles. 
1.1.2.1 Asymmetric allylic alkylation of 2-alkylazaarenes 
The group of Trost and co-workes had investigated a Pd-catalysed asymmetric allylic 
alkylation (AAA) reaction of 2-alkylazaarenes with π-electrophilies.
[26],[27],[28]
 In 
2008, they published their work regarding a Pd-catalysed process of 2-
methylpyridines 1.35 with cyclic tert-butyl carbonates 1.36 resulting in the synthesis 
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Scheme 1.20: Pd-catalysed asymmetric allylic alkylation of 2-methyl pyridyl  
                                    nucleophiles 1.35 with Boc-protected cyclic alcohols 1.36.
[26]
 
The studies revealed that the employment of the Lewis acid BF3·OEt2 was necessary 
to “soften” 2-methylpyridine 1.35 and make it more prone for the deprotonation 
using non-nucleophilic base, LiHMDS.  
A year later, Trost and co-workers published an extension of their work regarding 
more substituted 2-alkylpyridines.
[27]
 They envisioned that due to coordination of 
BF3·OEt2 to the nitrogen of the pyridine, the deprotonation of the starting material 
would only form a single geometric isomer due to the steric hindrance. If that would 
be the case, the final product should be obtained with high diastereo- and 
enantiocontrol (Scheme 1.21). 
 
Scheme 1.21: Plausible mechanism for AAA of 2-alkenylpyridines with pivalate carbonates  
                        under Pd-catalysis. 
Previously described reaction conditions that were used in AAA of 2-methyl pyridyl 
nucleophiles 1.35 (Scheme 1.20) were applied for more substituted alkylazaarenes 
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full conversion. The authors suggest that n-BuLi deprotonates HMDS, which is 
formed due to deprotonation of the α-proton of the starting material (Scheme 1.22). 
In general, substrates containing 2-alkyl and 2-aryl substituents at the pyridine ring 
were very well tolerated (compounds 1.40a, 1.40b, 1.40d–f) as well as heteroatom-
containing compound 1.40c, forming a new C–N stereocentre. Furthermore, 
compound 1.40f containing an aryl bromide moiety did not undergo oxidative 
addition with Pd(0) or lithium-halogen exchange with n-BuLi.  
 
Scheme 1.22: AAA of 2-substituted alkyl pyridines 1.38 with cyclic pivalate esters 1.39.
[27]
 
Further investigation by Trost and co-workers led to the development of a general 
method which can be used not only for 2-alkyl pyridines but a wide range of 
polyheteroaromatics 1.41 (Scheme 1.23).
[28]
 Their observations proved that substrate 
preactivation using BF3·OEt2 is not necessary for compounds containing more than 
one C=N moiety. Moreover, the reaction does not require n-BuLi as an additional 
external base, for complete conversion. Changing the leaving group for a more bulky 




THE UNIVERSITY of EDINBURGH 
 
strongly basic conditions, neither the formation of cyclohexadiene nor doubly 
alkylated product was observed. 
 
Scheme 1.23: AAA of polyheteroaromatics 1.41 with cyclic mesylate esters 45 under 
                             Pd catalysis.
[28]
 
Although, the described methodologies provided a wide range of interesting 
azaaromatics in good to high yields and enantio- and diastereoselectivities, formation 
of a nucleophile required the introduction of a strong base and an activating reagent 
in some cases. The possibility of using milder reaction conditions, from a synthetic 
point of view, would be of high interest. 
The first attempts to run this type of reaction under milder reaction conditions were 
reported in 1983 by the group of Hamana.
[29]
 They reported an aldol-type reaction of 
2-methyl azaarenes 1.41 with benzaldehyde 1.44 using 9-BBN triflate as an 
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Scheme 1.24: Aldol-type reaction of 2-methyl azaarenes 1.41 with benzaldehyde 1.44.
[29]
 
Further investigation towards stereoselective variants of this reaction revealed the 
aldol-type products could be obtained in good to high yield and high syn 
diastereoselectivity under the same conditions (Scheme 1.25).
[30]
 Enantioselective 
variants of this reaction had not been described. 
 
Scheme 1.25: Stereoselelective synthesis of 1.46 in the reaction of 2-substituted pyridines  
                         1.38 with benzaldehyde 1.44.
[30]
 
Until 2010 not much progress had been made in activation of 2-alkylazaarenes 
pronucleophiles under mild conditions. In 2010, the group of Huang and co-workers 
reported the Pd-catalysed nucleophilic addition of 2-methylazaarenes 1.41 to N-tosyl 
imines 1.47a (Scheme 1.26).
[31]
 In the presence of the Lewis acid Pd(OAc)2, 1,10-
phenanthroline and polar solvent THF, the reaction proceeded smoothly giving high 
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Scheme 1.26: Nucleophilic addition of 2-methylazaarenes 1.41 to N-tosyl imine 1.47a under 
                        Pd-catalysis.
[31]
 
The role of Pd(OAc)2 is shown in Scheme 1.27. It is believed that Pd(OAc)2 
coordinates to 2,6-lutidine 1.41a to generate complex 1.49. Then, deprotonation of 
the methyl group occurs by one of the acetates, forming species 1.50 and acetic acid. 
Coordination of the imine 1.47a gives intermediate 1.51 which then undergoes 
nucleophilic addition to furnish the final product 1.48a. 
 
Scheme 1.27: Plausible mechanism for Pd-catalysed nucleophilic additions of 2- 
                                 methylazaarene 1.41a to N-tosyl imine 1.47a.
[31]
 
Further investigation of this methodology was described by the same group in 
2010.
[32]
 They showed that replacing the Lewis acid Pd(OAc)2 with Sc(OTf)3 and 
using trifluorotoluene instead of THF at 120 °C provided an easy access to a series of 
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Scheme 1.28: Sc-catalysed nucleophilic additions of 2-substituted azaarenes 1.41 to N- 
                            sulfonyl aldimines 1.47a.
[32]
 
The proposed mechanism is analogous to the previously postulated Pd(II)-catalysed 
process (Scheme 1.27). 
These reaction conditions were also used to provide a broad range of 3-substituted 
isoindolinones 1.53 in a one-pot fashion (Scheme 1.29). Formation of the desired 
product consists of a two-step process, intermolecular nucleophilic addition of 2-
substituted azaarene 1.41 to N-tosyl imine 1.52 followed by an intramolecular 
amidation reaction. 
 
Scheme 1.29: Synthesis of 3-substituted isoindolinones 1.53 under Sc-catalysis.
[32]
 
A further example of this tandem process allowed the synthesis of various 
isoindolines 1.55 as single diastereoisomers, by applying bifunctional electrophile 
1.54 (Scheme 1.30). Formation of the addition product is followed by an 
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Scheme 1.30: Diastereoselective synthesis of isoindolines 1.55 from 2-methyl azaarenes  
                          1.41 with N-tosyl imine 1.54 under Sc-catalysis.
[32]
 
A year later, the same group discovered a new way of delivering 2-alkenylazaarenes 
1.8 via alkenylation of 2-alkylazaarenes 1.41.
[33]
 This process involves Fe-catalysed 
nucleophilic addition of 2-methyl azaarenes 1.41 to N-tosyl imines 1.47a followed by 
elimination of the N-tosyl group to furnish the final product 1.8 (Scheme 1.31). 
Moreover, the group of Wang showed that the formation of the 2-alkenylazaarenes 
1.8 is also possible when the reaction is run at reflux in toluene in the absence of 
Lewis acid.
[34]
 Recently, Xiao and co-workers also reported a catalyst-free synthesis 





Scheme 1.31: Synthesis of 2-alkenylazaarenes 1.8 under Fe-catalysis.
[33]
 
Similar results to those presented by Huang and co-workers were published by 
Rueping and Tolstoluzhsky.
[36]
 They showed that reaction of 2-methylalkylazaarenes 
1.41 with N-sulfonyl protected aldimines 1.56 catalysed by Cu(OTf)2 can provide the 
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Scheme 1.32: Cu-catalysed addition of 2-methylazaarenes 1.41 to N-sulfonyl imines 1.56.
[36]
 
An extension of this methodology was presented in work of Matsunaga and Kanai 
where 2-methyl-substituted azaarenes 1.41 were coupled with enones 1.58 under 





Scheme 1.33: Sc-catalysed addition of 2-methyl azaarenes 1.41 to enone 1.58.
[37]
 
In summary, it has been shown that 2-alkyl-substituted azaarenes can be used as 
nucleophiles under acid-catalysed conditions and can be successfully added to 
various electrophiles such as N-sulfonyl imines and enones. However, all of the 
presented examples highlighted problems regarding the development of an 
enantioselective variant. First the reversibility of this process,
[34]
 second, the harsh 
reaction conditions (high temperature and long reaction times necessary to obtain 
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1.1.3 INTRODUCTION OF A SECONDARY ACTIVATING GROUP AT THE 
REACTING CENTRE 
Introduction of a secondary activating group at the reacting centre of 2-alkyl 
azaarenes allows the reaction to proceed under milder conditions and led to the 
development of an enantioselective variant of the Michael process. Melchiorre and 
co-workers showed that the reaction of nitrobenzyl pyridines 1.60 with enals 1.61 
catalysed by chiral secondary amine 1.62 can provide a range of Michael addition 
products 1.63 in good to high yield and enantioselectivity (Scheme 1.34).
[38]
 Poor 
diasteroselectivity was reported 1.2-1.4:1, however an easy isolation of both 
diastereoisomers by flash chromatography was possible.  
 
Scheme 1.34: Asymmetric nucleophilic addition of nitrobenzyl pyridines 1.60 to enals 1.61  
                         with chiral organocatalyst 1.62.
[38]
 
This reaction progresses smoothly when pyridine and nitrobenzyl are attached to a 
methylene centre. As shown below, two effects are taking place in order to activate 
the nucleophile: stabilisation of the anion through conjugation to the nitro group 
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Scheme 1.35: Pro-nucleophilic activation via delocalisation with NO2 (A) and  
                        heteroaryl (B). 
A similar approach was considered at that time by the Lam group. They wondered if 
the employment of an ester as the acidifying group would increase the reactivity of 
alkylazaarenes. They found that azaarylacetates 1.64 underwent enantioselective 
nucleophilic addition to nitroalkenes 1.65 in the presence of a chiral nickel(II)-
bis(diamine) complex 1.66 to give the Michael products 1.67 in good to high yields, 
dr’s and ee’s. Unfortunately, some of the products tend to epimerise via enolisation 
under the optimised conditions due to the high acidity of the proton at the α-position 




Scheme 1.36: Asymmetric nucleophilic Michael additions of azaarylacetates 1.64 to 
                              nitroalkenes 1.65 under Evans nickel complex 1.66.
[39]
 
Next, azaarylamides 1.68 were examined in order to broaden the reaction scope 
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azaarylamides 1.69 did not undergo enolisation at the α-position to the stereogenic 




Scheme 1.37: Ni-catalysed azaarylamides 1.68 nucleophilic addition to nitroalkenes 1.65.
[39]
  
Based on previously reported mechanistic studies of the diamine ligand by the Evans 
group,
[41]
 Lam et al. proposed a stereochemical model to explain the diastereo- and 
enantioselectivity of these reactions. For illustrative purposes benzothiazole amide 
1.68d is chosen. The proposed model is based upon the following assumptions: 1) 
one of the diamine ligands is fully displaced from the catalyst 1.66 by the starting 
material. The free ligand then deprotonates the metal-bound azaarylamide. 2) The 
oxygen of the formed enolate and the azaarene nitrogen coordinate to the nickel 
centre. 3) The nitroalkene 1.65 is bound to nickel to stabilise the developing negative 
charge of the nitronate anion. Thus, the described reactions by Lam and co-workers 
go through TS1.1 which is free of unfavourable interactions and it is consistent with 
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Scheme 1.38: Stereochemical model for the reaction outcome.
[39]
  
Activation of alkylazaarenes can be also achieved when an electron-withdrawing 
group is installed on the azaarene such that conjugation with the C=N moiety is still 
possible. This allows resonance stabilisation of the anion which is formed by α-
deprotonation of the azaarene (Scheme 1.39). 
 
Scheme 1.39: Pro-nucleophile activation via introduction of an electron-withdrawing group. 
Based on this hypothesis the group of Adamo and co-workers described a new 
variant of the Henry reaction between 3,5-diethyl-4-nitroisoxazoles 1.70 and 
carbonyl compounds 1.71. The reaction proceeded in the presence of 30 mol% of 
triethylamine in methanol giving the addition product 1.72 in high yield and low to 
moderate diasteroselectivities (Scheme 1.40).
[42]
 The products delivered from 
(hetero)aryl aldehydes tended to epimerise more readily in comparison with alkyl- 
derived products due to the higher acidity of the methylene group. Compounds 1.72a 
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Scheme 1.40: Henry reaction of 3,5-diethyl-4-nitroisoxazoles 1.70 and aldehydes 1.71 
                            under mild basic conditions.
[42]
 
Our group had also applied this strategy in the process of enantio- and 
diatereoselective nucleophilic addition of 2-alkylazaarenes with N-Boc imines and 
nitroalkenes.
[43]
 The detailed studies regarding this process can be found in the 
Results and Discussion Part of this thesis (See Section 1.3). 
The group of Li and Wang
[44]
 also later showed that the employment of the strongly 
electron-withdrawing nitro group can alter the electronic properties of the 
alkylazaarenes in order to activate the benzylic position towards the nucleophilic 
attack. The reaction of 4-methyl-3-nitropyridines 1.73 with α,β-unsaturated 
aldehydes 1.61 catalysed by the diphenylprolinol diethyl silyl ether 1.74 via iminium 
catalysis led to the enantioselective formation of a new C–C bond generating 
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Scheme 1.41: Enantioselective Michael additions of 4-methylazaarenes 1.73 to enals 1.61  
                          with proline-derived organocatalyst 1.74.
[44]
 
The group of Rios and co-workers investigated this area further and showed that 
nitro-substituted alkylazaarenes 1.76 can be added to enals 1.61 in the presence of 
proline-derived chiral catalyst 1.77. However, as the formed product was found to be 
unstable, subsequent manipulation was required that led to formation of the Wittig 
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Scheme 1.42: Synthesis of 1.78 after Michael addition and Wittig reaction.
[45]
 
In summary, a few examples were presented where activated alkylazaarenes undergo 
nucleophilic additions to various electrophiles such as α,β-unsaturated carbonyl 
compounds, imines and nitroalkenes. The reactions work under relatively mild 
conditions only if the second activating group is either attached to the reacting centre 
or to the azaarene itself. 
1.1.4 2-ALKENYLAZAARENES AS LATENT NUCLEOPHILES IN 
ADDITION REACTIONS 
As discussed in the previous section, formation of a nucleophile from 2-
alkylazaarenes via α-deprotonation provides the formation of an azaallylmetal 
intermediate which reacts with an electrophile to form a new C–C bond. Another 
approach which provides these types of species is the hydrometallation of 2-
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Scheme 1.43: Formation of an azaallyl metal intermediate from 2-alkenylazaarenes. 
The group of Krische described the first metal-catalysed reductive coupling of vinyl 
azines 1.6 with N-sulfonyl imines 1.47 to give the final pyridinylsulfone amide 
product 1.79 as a single regio- and diastereoisomer (Scheme 1.44).
[46]
 The catalytic 
system of 5 mol% [Rh(cod)2]BARF catalyst, 12 mol% phosphine ligand, and 2 
equivalents of Na2SO4 as an imine hydrolysis suppressor was efficient in the reaction 
of 6-substituted vinylazines with N-sulfonyl imines. However, under the optimised 
reaction conditions, 2-vinylpyridine which lacks a substituent at the 6-position, failed 
in generating the final product due to strong coordination at nitrogen.  
 
Scheme 1.44: Rh-catalysed reductive coupling of vinyl azaarenes 1.6.
[46]
  
The Lam group previously described enantioselective copper-catalysed reductions of 
β,β-disubstituted alkenylazaarenes that led to the formation of chiral alkylazaarenes 
(Section 1.1.1, Scheme 1.3),
[13]
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which are then quenched with t-BuOH to furnish the final product. Based on the 
proposed mechanistic explanation, they wondered if the organocopper species could 
be trapped with a π-electrophile instead of a proton. The investigation revealed that 
various vinyl azaarenes 1.80 underwent enantioselective copper-catalysed reductive 
coupling with ketones 1.81, using PhSiH3 as the stoichiometric hydride source. The 
Taniaphos ligand L1.6 was found to be the most effective chiral bisphosphine ligand 
among those screened in delivering the products in high enantio- and 
diastereoselectivities (Scheme 1.45).
[47]
 Various heterocycles were tolerated such as 
pyridines (1.82a), (iso)quinolines (1.82b–c), pyrimidines (1.82d), diphenyloxazoles 
(1.82e) and triazines (1.82f). Furthermore, β-substituted azaarenes were also 
effective in this process (1.82e–f). With respect to ketones both acyclic and cyclic 
were successful coupling partners. 
The stereochemistry of the final products is dependent on the structure of the starting 
materials. Different stereochemistry was generated even though the same enantiomer 
of the ligand L1.6 was used in this reaction (see (iso)quinoline-derived products 
1.82b and 1.82c to compare). Similarly, the stereochemical outcome is different for 
acyclic and cyclic ketones (see examples 1.82b–c and 1.82e–f). The reasoning is not 
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Scheme 1.45: Reductive coupling of alkenylazaarenes 1.80 with ketones 1.67.
[47]
 
Further investigation by the same group with regards to π-electrophiles as potential 
coupling partners for this transformation led to the recently published work on the 
enantioselective copper-catalysed reductive coupling of vinylazaarenes 1.80 with N-
Boc protected aldimines 1.83.
[48]
 During the extensive studies, they found that in the 
presence of (S)-DTBM-SEGPHOS bisphosphine ligand L1.7 (5 mol%), 1,1,3,3-
tetramethyldisiloxane (TMDS, 1.2 equivalents), the reaction proceeded smoothly in 
THF at room temperature to give reductive coupling products 1.84 as the anti-
diastereomer, opposite to that observed by the Krische group
[46]
 (Scheme 1.46). 
Pleasingly, the reaction worked for a broad range of vinylazaarenes such as 
quinolines 1.84a, pyrimidines 1.84b, pyridines 1.84c, benzothiazoles 1.84d, 1.84e, 
1.84g and benzoxazoles 1.84f. In terms of the tested N-Boc protected aldimines, 
various substituents were tolerated at different positions on the phenyl ring. 
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1.2 CONCLUSIONS 
To summarise, it has been shown that azaarenes are important molecules that can 
provide complex products in an enantio- and diasteroselective fashion. 
Alkenylazaarenes can act as electrophiles due to the electron-withdrawing C=N 
moieties embedded in their structures, and provide Michael addition products with 
excellent stereoselectivity. In addition, alkylazaarenes may act as nucleophiles once 
activated, and can be then trapped with various π-electrophiles to release interesting 
molecules.  
In the Results and Discussion section, studies regarding 2-alkylazaarenes as 
pronucleophiles in addition reactions to N-Boc imines and nitroalkenes catalysed by 
a chiral Pd(II)-bisoxazoline complex will be described. Prior to this work, no 
enantioselective variant of this reaction was known. Furthermore, the final product 
can be functionalised further to give a wide range of chiral amines, which are 
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1.3 RESULTS AND DISCUSSION  
Unless stated otherwise conversions and diastereomeric ratio were determined by 
1
H NMR 
analysis of the unpurified reaction mixtures. Yields are of pure isolated products. 
Enantiomeric excesses of the major diastereomer determined by chiral HPLC analysis. 
1.3.1 CATALYTIC SOFT ENOLISATION OF HETEROARENES FOR 
ASYMMETRIC C–C BOND FORMATION 
The first part of the introduction provides information regarding synthetic strategies 
which enable functionalisation of alkylazaarenes via C–H deprotonation. As the 
acidity of the methylene group of alkylazaarenes is low, (e.g. for 2-benzylpyridine 
pKa = 28.2 in DMSO), harsh conditions such as long reaction times, the addition of 
an external base or high temperatures are often required to achieve reasonable yields 
(Scheme 1.47A). Most of the literature precedent covers racemic examples of the 
nucleophilic additions of alkylazaarenes to imines or nitroalkenes and to the best of 
our knowledge; an enantioselective variant has not yet been reported. At this stage, 
we considered whether having an electron-withdrawing group attached to a 
heterocycle would help to acidify the α-proton, allowing milder and thus more 
suitable conditions for asymmetric catalysis (Scheme 1.47B).  
 
Scheme 1.47: Azaaromatics as substrates in Mannich-type reactions. 
1.3.2 SYNTHESIS OF 2-ALKYLSUBSTITUTED AZAARENES 
The synthesis of 2-alkylazaarenes is straightforward. In general, commercially 
available amino-alcohols and amino-thiols were condensed with orthoesters to give 
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Table 1.1: Synthesis of benzoxazoles and benzothiazoles.
[43] 
 



















































          Reactions conducted on a: 
a








3.00 mmol,  







An alternative approach was used for obtaining pyrroloquinazolinone 1.88 by 
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1.48A) in the presence of POCl3. Also, 3-nitropyridines 1.91 were synthesised by the 
nucleophilic aromatic substitution of chloropyridine 1.89 with ethyl malonates 1.90 
followed by hydrolysis and decarboxylation (Scheme 1.48B).
 
 
Scheme 1.48: Synthesis of various alkylazaarenes.  
1.3.3 SCREENING OF VARIOUS ELECTROPHILES 
The reaction between commercially available 2-methyl-6-nitrobenzoxazole 1.85a 
and p-nitrobenzaldehyde 1.92a was chosen for catalyst development. Screening of 
various acetate sources, used as bases in this case to deprotonate the α-proton in 
1.85a, revealed that the combination of AgOAc (12 mol%) and rac-BINAP (12 
mol%) was the most efficient catalytic system, while other Lewis acids gave either 
lower conversion or the desired product was not observed (Table 1.2, entries 1–6). A 
control experiment showed that no reaction occurred in the presence of the Lewis 
acid only. Changing the ligand for 2,2`-BiPy was less effective at room temperature 
(Table 1.2, entry 7) and heating the reaction to 100 °C did not significantly improve 
conversion (~45%). Furthermore, switching from THF to 1,4-dioxane  and carrying 
out reaction at room temperature, 60 °C and 100 °C gave 1.93a in 16%, 11% and 
30% conversion, respectively. Other metal acetates such as In(III), Pd(II), Ni(II), 
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Table 1.2: Screening of reaction conditions.
 
 












2 CuOAc rac-BINAP THF 10 
3 Cu(OAc)2 rac-BINAP THF 33 
4 In(OAc)3 rac-BINAP THF <5 
5 Pd(OAc)2 rac-BINAP THF <5 
6 Ni(OAc)2 rac-BINAP THF <5 
7 AgOAc 2,2’-BiPy THF 42 
8 CuOAc 2,2’-BiPy THF <5 
9 Cu(OAc)2 2,2’-BiPy THF <5 
10 In(OAc)3 2,2’-BiPy THF <5 
11 Pd(OAc)2 2,2’-BiPy THF 7 
12 Ni(OAc)2 2,2’-BiPy THF 6 
 
To broaden the reaction scope, a range of heterocycles 1.85 and 1.88 were reacted 
with p-nitrobenzaldehyde 1.92a (Table 1.3). The combination of rac-BINAP with 
AgOAc in THF was, in most cases, a good catalytic system. The highest conversion 
was observed for heterocycles 1.93b, 1.93l–n, which were obtained in 73%, 72%, 
66% and 56%, respectively (Table 1.3, entries 1–4); heterocycles 1.85o–r, gave the 
desired product in low conversion between 26 and 40% (compounds 1.93o-r). The 
product 1.94a derived from the heterocycle 1.88 was identified by NMR analysis; 
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Unless stated otherwise conversions were determined by 
1
H NMR analysis of the unpurified reaction 
mixture, ND – not determined  
Although the aforementioned heterocycles were not providing generally good yields 
for the addition products, we decided to investigate if the nucleophilic addition 
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A variety of chiral ligands were evaluated in the model reaction of 2-ethyl-6-nitro-
1,3-benzoxazole 1.85b and p-nitrobenzaldehyde 1.92a. Unfortunately, the addition 
product 1.93a was obtained as a racemate and with low diastereoselectivity ranging 
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In light of these results, our new strategy was to test different classes of π-
electrophiles which might provide the addition product in good yields and 
enantioselectivity. Contemporaneously, within our group the reaction of N-DPP-
imine 1.95 and various benzoxazoles 1.85a–d was being investigated (Scheme 1.49). 
In the presence of AgOAc and various chiral ligands, a number of alkylheteroarenes 
were explored. Unfortunately, conditions giving both high ee’s and dr’s could not be 
found.  
 
Scheme 1.49: Nucleophilic additions of azaarenes 1.85 to N-DPP imine 1.95. 
Although N-DPP imines showed some promise, they were not giving consistent 
results, so our efforts were directed towards other classes of imines.  
Our investigation started with screening sulfamoyl-imine 1.97 against 6-nitro-2-
propyl-1,3-benzoxazole 1.85c (Table 1.5). This study identified AgOAc (12 mol%) 
and rac-BINAP (12 mol%) in THF at room temperature to be the most suitable 
reaction conditions (Table 1.5, entry 1) giving the desired racemic product in 70% 
conversion. The [AgOAc/2,2’-BiPy/THF] catalytic system was also effective but 
lower conversion was observed (Table 1.5, entry 2). Unfortunately, no improvement 
was obtained when various Lewis acids were tested, such as CuOAc, Cu(OAc)2, 
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Table 1.5: Scope of racemic reaction.
 
 












2 AgOAc 2,2’-BiPy 51 2.7:1 
3 CuOAc rac-BINAP <5 ND 
4 Cu(OAc)2 rac-BINAP <5 ND 
5 Pd(OAc)2 2,2’-BiPy 20 6.7:1 
ND – not determined 
To develop an asymmetric version of this reaction, next, various co-catalysts 
AgOAc, Pd(OAc)2, CuOAc and Cu(OAc)2 were screened along with a variety of 
chiral ligands (Table 1.6). A very encouraging result 64%, 94% ee, >19:1 dr (Table 
1.6 entry 13) was obtained using 12 mol% Pd(OAc)2 and (S)-DM-SEGPHOS L1.29 
in THF at room temperature. Running the reaction on 0.5 mM scale conversion 
reached up to 80%. A solvent screen at room temperature indicated that changing 
THF for DME gave a comparable outcome (63%, 91% ee) but a decrease in dr was 
observed (9:1), (Table 1.7 entry 2). Higher conversion was generally observed with a 
AgOAc catalyst, but the ee was <50% with various ligands and the dr was highly 
variable (Table 1.6, entries 1–2, 5–6). CuOAc and Cu(OAc)2 in combination with 
(S)-DM-SEGPHOS L1.29 gave similar results, both giving 40–50% conversion but 
low enantiomeric excess between 15–20%, however a complete reversal of dr was 
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Table 1.6: Ligand optimisation.
 
 


















2 AgOAc L1.9 74 1.4:1 19(13) 
3 Pd(OAc)2 L1.28 35 2.3:1 11(37) 
4 Pd(OAc)2 L1.9 47 7.3:1 13(3) 
5 AgOAc L1.20 76 1.7:1 10(10) 
6 AgOAc L1.10 43 4.8:1 40(0) 
7 Pd(OAc)2 L1.20 18 7.3:1 3(20) 
8 Pd(OAc)2 L1.10 <5 ND ND 
9 AgOAc L1.15 <5 ND ND 
10 AgOAc L1.29 76 3.2:1 47(7) 
11 AgOAc L1.16 65 2.2:1 23(0) 
12 Pd(OAc)2 L.15 <5 ND ND 
13 Pd(OAc)2 L1.29 64 >19:1 94 
14 Pd(OAc)2 L1.16 21 >19:1 63 
15 AgOAc L1.8 80 1.3:1 ND 
16 AgOAc L1.13 <5 ND ND 
17 AgOAc L1.18 <5 ND ND 
18 AgOAc L1.19 <5 ND ND 
19 Pd(OAc)2 L1.8 60 4.5:1 20(65) 
20 Pd(OAc)2 L1.13 <5 ND ND 
21 Pd(OAc)2 L1.18 <5 ND ND 
22 Pd(OAc)2 L1.19 <5 ND ND 
23 CuOAc L1.29 51 1:5.6 19(13) 
24 Cu(OAc)2 L1.29 38 1:5.6 23(17) 
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In an attempt to simultaneously lower the catalyst loading and increase conversion, a 
solvent screen at higher temperature was also conducted (Table 1.7). This screen 
indicated that elevated temperatures resulted in a significant decrease in ee, though 
high ee could be still obtained at 60 °C in DCE (91% ee), although use of DCE led to 
a decrease in conversion (Table 1.7 entry 7). Unfortunately, an increase to a higher 
temperature (100 °C) revealed thermal instability of the catalyst (Table 1.7, entries 
8–9). As part of an ongoing ligand screen, application of the Ph-DM-Box ligand 
L1.30 in combination with Pd(OAc)2 gave the addition product 1.98c in conversion 
greater than 90%, 14:1 dr and 89% ee (Table 1.7, entry 10). This result provided our 
best combination of conversion and stereoselectivity to date. 
Table 1.7: Solvent and temperature screening.
 
 










1 L1.29 THF RT 12 64 >19:1 94 
2 L1.29 DME RT 12 63 9:1 91 
3 L1.29 DCE RT 12 <5 - - 
4 L1.29 THF 60 5 39 9:1 67 
5 L1.29 DME 60 5 26 9:1 ND 
6 L1.29 toluene 60 5 43 9:1 77 
7 L1.29 DCE 60 5 59 9:1 91 
8 L1.29 dioxane 100 5 <5 - - 
9 L1.29 DCE 100 5 <5 - - 
10 L1.30 THF RT 10 >90 14:1 86 
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At this stage, deprotection of the product was investigated to establish the potential 
synthetic utility of this process. According to literature procedures,
[49], [50]
 the 
treatment of sulfamoyl-protected amine product 1.98c with diamines at reflux or 
under microwave irradiation should cleave the sulfamoyl group giving the desired 
free amine 1.99c (Scheme 1.50). Unfortunately, none of the applied methods gave 
the desired product, instead complex mixtures were obtained, even at room 
temperature. According to literature precedent,
[51]
 it is highly likely that the reduction 
of the aromatic nitro group may occur under these conditions which would explain 
the failure of this transformation. Attempts to cleave the sulfamoyl group with HCl 
(6 M) led to slow hydrolysis of the benzoxazole to the corresponding amide, and no 
detectible sulfamoyl hydrolysis. This deprotection problem was not investigated any 
further and it was decided to change our strategy slightly.  
 
Scheme 1.50: Attempts of deprotection of product 1.98c. 
In light of the results obtained, alternative imines were reconsidered in our studies 
(Figure 1.2). We were interested in coupling the alkylazaarenes with imines that have 
a cleavable protecting group. For instance, we excluded N-tosyl imine 1.100 as the 
protecting group in the product would be difficult to cleave and thus the products 
would have very little synthetic utility. N-Nosyl-imine 1.101 proved to have very low 
reactivity under a variety of conditions and pyridylsulfonyl-imine 1.102 showed only 
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these imines was not observed in the presence of Pd(OAc)2, CuOAc or Cu(OAc)2 
catalysts.  
 
Figure 1.2: Various N-protected imines used for the nucleophilic addition reactions with  
                        alkylazaarenes. 
1.3.4 N-BOC PROTECTED IMINES AS ELECTROPHILES IN NUCLEOPHILIC 
ADDITION REACTIONS  
Next, our efforts were focused on N-Boc-protected imines. The deprotection of the 
product is facile, making N-Boc imines very attractive electrophiles. The synthesis of 
the protected imines is well documented in the literature, whereby formation of 
sulfonyl carbamates 1.103 is followed by treatment with base to give N-Boc imines 
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N-Boc imines proved to be very suitable electrophiles for the addition of 2-
alkylazaarenes. As shown below in Table 1.9, 6-nitro-2-propyl-1,3-benzoxazole 
1.85c and N-Boc imine 1.83a were screened in combination with various ligands and 
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rac-BINAP in THF were applied, giving the corresponding adduct 1.104c in 80% 
conversion (Table 1.9, entry 3).  CuOAc, Cu(OAc)2 and Pd(OAc)2 in combination 
with dppe or 2,2’-BiPy ligands were not effective for this reaction. 
Table 1.9: Reaction conditions for the model reaction. 
 









2 Cu(OAc)2 rac-BINAP <5 
3 AgOAc rac-BINAP 80 
4 Pd(OAc)2 rac-BINAP <5 
5 CuOAc Dppe 30 
6 Cu(OAc)2 Dppe 26 
7 AgOAc Dppe <5 
8 Pd(OAc)2 Dppe <5 
9 CuOAc 2,2’-BiPy <5 
10 Cu(OAc)2 2,2’-BiPy <5 
11 AgOAc 2,2’-Bipy <5 
 a
Unless stated otherwise conversions were determined by 
1
H NMR   
  analysis of the unpurified reaction mixture 
With these results, our focus turned to the development of an enantioselective 
version of this reaction. A particularly active catalyst [Pd(OAc)2, Ph-DM-Box L1.30] 
effective in the studies with sulfamoyl-imines before, was used in the reaction of 
propylbenzoxazole 1.85c with phenyl N-Boc imine 1.83a to give chiral amine 
1.104c. Pleasingly, high conversion, ee and dr were observed at room temperature, 
and largely conserved at 50 °C, a temperature which allowed a much shorter reaction 
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Scheme 1.51: Addition reaction of azaarene 1.85c to N-Boc imine 1.83a. 
The optimised reaction conditions were applied to other heterocyclic substrates, 1.85 
and 1.88 to assess the substrate scope of the nucleophilic addition process (Scheme 
1.52). Disappointingly, these conditions did not appear to be very general. For 
instance, whilst the benzoxazole addition products 1.104s or 1.104t were obtained 
with high yields, the enantio- and diastereoselectivity was low to moderate. Heating 
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Scheme 1.52: Screening of various heterocycles with N-Boc protected imine 1.83a. 
In light of these results, our efforts were focused on synthesising more sterically 
bulky version of ligand L1.30 to see if the stereoselectivity could be improved. A 
tetraphenylbis(oxazoline) TPDM-Box ligand L1.31 was investigated. Pleasingly, the 
reaction of 2-ethyl-benzoxazole 1.85b with N-Boc imine 1.83a in the presence of the 
chiral complex composed of 5 mol% Pd(OAc)2 and a TPDM-Box ligand L1.31 
delivered the final product 1.104b in a great yield and enantioselectivity (Scheme 
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Scheme 1.53: Nucleophilic addition of 2-ethyl-benzoxazole 1.85b to N-Boc imine 1.83a. 
1.3.5 SUBSTRATE SCOPE 
2-Alkylazaarenes 
Application of the optimised conditions in the reaction of various azaarenes with 
phenyl N-Boc-protected imine 1.83a gave the addition products in excellent yields, 
good to high enantio- and diastereoselectivity (Scheme 1.54). 2-Alkyl-6-
nitrobenzoxazoles 1.85c and 1.85d containing an ethyl or n-propyl substituent at the 
α-position were tolerated and delivered the addition products in high yield, enantio- 
and diastereoselectivity at room temperature. (Scheme 1.54, compounds 1.104c and 
1.104d). With respect to 2-methoxy-6-nitrobenzoxazole 1.85e, the reaction 
proceeded smoothly but gave only a 5:1 mixture of disatereosisomers (product 
1.104e). Unfortunately, 2-methyl-6-nitrobenzoxazole 1.85a did not give the expected 
product but double substitution was observed instead. Changing the nitro group at the 
6-position of alkylazaarene for either an ester or cyano group required heating the 
reaction at 50 °C due to the lower reactivity of the starting materials (products 
1.104f–h). Enantio- and diastereoselectivity was, in these cases, still high in 
comparison to the corresponding reactions carried out at room temperature. This 
process is also applicable to other azaarenes such as 6-nitrobenzothiazole 1.85i, 
which gave the addition product 1.104i in 78% yield, 10:1 dr and 99% ee, as well as 
for 3-nitropyridines where the products (1.106a and b) were obtained in high yield 
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Scheme 1.54: Enantioselective Pd-catalysed addition of various 2-alkylazaarenes to phenyl  
                        N-Boc imine 1.83a. 
In order to broaden the reaction scope, we focused on various aromatic N-Boc-
protected aldimines 1.83 (Scheme 1.55). Aromatic imines with substituents at the 
para and the meta positions at the phenyl ring (such as methyl, bromo, chloro, nitro, 
cyano or methoxy) underwent the addition reaction successfully with a range of 
different 2-alkylazaarenes in high yield, enantio- and diastereoselection. These 
reaction conditions were also applied to an ortho substituted aromatic imine and gave 
the expected product in high yield and enantioselectivity but with moderate 








Scheme 1.55: Enantioselective Pd-catalysed additions of alkylazaarenes to various N-Boc  
                           imines. 
Nitroalkenes 
Having assessed the scope of N-Boc-protected imines tolerated in the Pd-catalysed 
nucleophilic addition reactions of alkylazaarenes, we next investigated alternative π-
electrophiles to further expand this process. Pleasingly, it was found that this process 
was not only limited to aromatic N-Boc imines; nitroalkenes were also effective 
coupling partners under identical conditions. As demonstrated, substrates 1.85d and 
1.91b, gave the addition products as a single diastereoisomer with high 
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Scheme 1.56: Enantioselective Pd-catalysed additions to nitroalkenes. 
1.3.6 THE ROLE OF THE ELECTRON-WITHDRAWING GROUP IN THE 
AZAARENE 
After having generated a range of chiral, protected amines with high molecular and 
stereochemical complexity, we decided to investigate the importance of the position 
of the electron-withdrawing group at the azaarene. It was decided to prepare 2-ethyl-
5-nitrobenzoxazole 1.85j in which the nitro group is not conjugated to the developing 
negative charge on deprotonation. The reaction of 1.85j with phenyl-N-Boc imine 
1.83a was conducted under previously optimised conditions. Despite the lack of 
conjugation, the coupled product 1.104j (Scheme 1.57, entry 1) was obtained as a 
16:1 inseparable mixture of diastereoisomers in 74% yield, with enantiomeric excess 
of 90% and 78% for the major and minor diastereomers, respectively. Interestingly, 
since the stabilisation of the conjugate base of 1.85j by the mesomeric effect is not 
possible in this case, it suggests that the inductive effect of the nitro group is 
sufficient for the reaction to proceed. This shows the possibility of broadening the 
reaction scope for substrates bearing an electron-withdrawing group at the 5-position. 
Conducting the reaction with conjugated nitro derivative 2-ethyl-4-nitrobenzoxazole 
1.85k, gave the final product 1.104k in poor yield and diastereoselectivity. This 
result may possibly be explained by the coordination of the nitro group to the metal 
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Scheme 1.57: Variation of an electron-withdrawing group on azaarene. 
1.3.7 MANIPULATION OF THE PRODUCT VIA DEPROTECTION OF N-BOC 
GROUP 
Ideally for this new enantioselective methodology for the alkylation of N-Boc imines 
to be a useful synthetic approach, the nitrogen protecting group should be readily 
cleaved. Removal of the N-Boc protecting group was conducted by generating dilute 
HCl in situ from TMSCl in methanol. This allowed the formation of the free chiral 
amine product under relatively mild conditions (Scheme 1.58). The products 1.110d 
and 1.110b were obtained in 90% and 93% yield respectively, with a very small 
erosion of diasteroselectivity in the latter case. 
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1.3.8 THE ROLE OF THE COUNTERION ON THE REACTION OUTCOME 
We also explored if any of other carboxylate counterions can be used as alternatives 
to metal acetates. The general reaction between 2-ethyl-6-nitrobenzoxazole 1.85b 
and phenyl N-Boc imine 1.83a was run under standard conditions but with Pd(TFA)2 
in place of Pd(OAc)2 (Scheme 1.59). However, not even a trace of product was 
obtained. With an addition of 10 mol% Et3N, the conversion reached only 34%. As 
trifluoroacetates are less basic than acetate anions the addition of an external base 
was needed. Then, an analogous experiment was conducted using Pd(OBz)2, which 
gave the addition product in 90% yield, 3:1 dr and 87% (97%) ee (major/minor). 
Finally, changing the anion by using Pd(OPiv)2 gave the desired product in only 38% 
yield. It is believed that benzoate and pivalate anions are more bulky than acetate 
which may explain low stereoselectivity observed. These results conclude that both 
the basicity and the size of the counterion are crucial for the reaction outcome.  
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1.3.9 X-RAY ANALYSIS AND STEREOCHEMICAL MODEL 
The relative and absolute stereochemistries of the addition products 1.106b, 1.110d, 
and 1.109b were determined by X-ray crystallography using a copper radiation 
source. The stereochemistries of the remaining products were assigned by analogy 
(Scheme 1.60) 
                                    
                                      
 
        
              
Scheme 1.60: Crystal structures of compounds 1.106b, 1.110d, 1.109b. 
Based on these results, a stereochemical model was proposed (Scheme 1.61) First, 
the deprotonation of an alkylazaarene by an acetate anion from the palladium 
complex 1.111 occurs, giving the Pd-bound azaallyl species 1.112. In this case the E-
stereochemistry has been adopted in order to minimise the steric interactions between 
the R-substituent and the other ligand. The imine approach is more likely to happen 
in this conformation as the top face is relatively unhindered. However, if the azaallyl 
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coordination/binding is disfavoured as the top face is hindered by the acetate ligand 
while the bottom face is blocked by the phenyl groups of the chiral complex. The 
formation of four distinct transition states from conformation 1.112 is plausible. In 
TS 1.4 and TS 1.5 the imine possesses an s-cis geometry which is unfavourable due 
to eclipsing interactions. However, in the case of the more favourable staggered 
conformations TS 1.2 and TS 1.3, where an imine adopts s-trans geometry, the latter 
is disfavoured as the tert-butyl group of the imine clashes with one of the methyl 
groups of the chiral ligand. Therefore, the reaction is believed to go through TS 1.2. 
A similar approach can be applied to the stereochemical outcome of the nitroalkene 
addition, through TS 1.6. 
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1.3.10 ELABORATION OF AN ADDUCT  
Finally, to further demonstrate the utility of our method we applied our conditions to 
the synthesis of a more complex biaryl adduct (Scheme 1.62). First, the reduction of 
the aromatic nitro group to an amine was achieved in the presence of metallic zinc, 
CuSO4 and acetic acid giving product 1.114 in 94% yield. Then, the conversion of 
this amine into brominated product 1.115 was achieved via the Sandmeyer reaction, 
followed by a Suzuki-Miyaura coupling with 4-methoxyphenylboronic acid to 
produce the final product 1.116 in 80% yield. 
 
Scheme 1.62: Further transformations of the addition product 1.106b. 
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1.4 CONCLUSIONS AND FUTURE WORK 
We have reported the palladium-catalysed enantioselective addition of 
alkylazaarenes to N-Boc imines using a bis(oxazoline) ligand to attain excellent 
enantioselectivities, diastereomeric ratios, and yields. These reaction proceed under 
mild conditions with no external base, no inert atmosphere and often ambient 
temperatures. The electron-withdrawing substitutent on the heterocycle was found to 
be essential to modulate the pKa sufficiently to allow the chiral palladium enolate to 
form. 
 
Scheme 1.63: Diastero- and enantioselective Pd-catalysed additions of 2-alkylazaarenes to  
                         N-Boc imines and nitroalkenes. 
 
We then extended this work to encompass nitroalkenes as the π-acceptors and 
demonstrates the the palladium enolate could undergo Michael addition with similar 




Scheme 1.64: Diastero- and enantioselective Pd-catalysed additions of 2-alkylazaarenes to  
                              nitroalkenes 
 
Finally, the judicious choice of using N-Boc imines as the Mannich acceptors 
allowed the facile removal of the protecting group to enable the rapid synthesis of the 
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Scheme 1.65: The deprotection of the product to give amine products 
Our efforts to extend this work are currently directed towards the investigation of α-
TMS-protected alkylazaarenes and their ability to act as nucleophiles in conjugate 
addition reactions with π-electrophiles. We believe that the formation of an enolate 
by desilylation rather than deprotonation of an alkylazaarene could be possible and 
the formation of a strong Si–X bond (X = O, F) would provide a thermodynamic 
driving force for this reaction. Also by using this method of activation, it may be 
possible to not require a strong electron-withdrawing group on the alkylazaarene. 
 
 
Scheme 1.66: Proposed activation of α-silyl hetercycles 
  
Previously we have reported alkenylazaarenes to be excellent latent nucleophiles, 
conjugate addition of a hydride using copper catalysis formed a copper-enolate 





to generate molecular complexity. We believe that similar palladium catalysed 
domino processes could be feasible to allow the generation of multiple stereocentres 
in one step. 
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1.5 EXPERIMENTAL  
This project was done in the collaboration with one of my work colleagues Dr Daniel 
Best. The data presented in this section represents experiments performed by me in 
regards to this project.  
General Information  
THF and CH2Cl2 were dried and purified by passage through activated alumina 
columns using a solvent purification system. All commercially available reagents 
were used as received. Thin layer chromatography (TLC) was performed on Merck 
DF-Alufoilien 60F254 0.2 mm precoated plates. Product spots were visualised by UV 
light at 254 nm, and subsequently developed using vanillin, potassium permanganate, 
or ceric ammonium molybdate solution as appropriate. Flash column 
chromatography was carried out using silica gel (Fisher Scientific 60 Å particle size 
35-70 micron) employing the step gradient elution in the mobile phase stated. 
Melting points were recorded on a Gallenkamp melting point apparatus and are 
uncorrected. Infra-red spectra were recorded on a Shimadzu IRAffinity-1 instrument 
as a thin film on sodium chloride plates or as a dilute solution in CHCl3. 
1
H NMR 
spectra were recorded on a Bruker AV500 (500 MHz), a Bruker AVA400 (400 
MHz) spectrometer, or a Bruker OPEN400 (400 MHz) spectrometer. Chemical shifts 
() are quoted in parts per million (ppm) downfield of tetramethylsilane, using 
residual protonated solvent as an internal standard (CDCl3 at 7.27 ppm, CD3OD at 
3.31 ppm, (CD3)2SO at 2.50 ppm). Abbreviations used in the description of 
resonances are: br (broad), s (singlet), d (doublet), t (triplet), q (quartet), quin 





NMR spectra were recorded on a Bruker AV500 (125.8 MHz) 
spectrometer. Chemical shifts () are quoted in parts per million (ppm) downfield of 
tetramethylsilane, using deuterated solvent as an internal standard (CDCl3 at 77.0 
ppm, CD3OD at 49.0 ppm, (CD3)2SO at 39.5 ppm). Assignments were made using 
the DEPT sequence with secondary pulses at 90° and 135°. High-resolution mass 
spectra were recorded on a Finnigan MAT 900 XLT spectrometer or a Finnigan 
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Swansea University, or on a Finnigan MAT 900 XLT spectrometer at the School of 
Chemistry, University of Edinburgh. Optical rotations were performed on an Optical 
Activity POLAAR 20 polarimeter with a path length of 1 dm. Chiral HPLC analysis 
was performed on an Agilent 1260 instrument using 4.6 x 250 mm columns. 
Authentic racemic samples of products for chiral HPLC assay determinations were 
obtained using rac-BINAP/AgOAc as the catalyst in THF, or rac-2,2-bis[2-(4-
phenyl-1,3-oxazolinyl)]propane/Pd(OAc)2 as the catalyst in CHCl3 or THF. 
 






Following a modified literature procedure,
[57]
 a suspension of the diamide S1 (558 
mg, 1.07 mmol) and (NH4)6Mo7O24·4H2O (190 mg, 0.154 mmol, 100 mol% Mo) in 
xylenes (50 mL) was heated at reflux using a Dean-Stark apparatus for 24 h. TLC 
analysis (40% acetone/hexane) revealed complete consumption of the diamide (Rf 
0.30) and the formation of a major product (Rf 0.60). The reaction mixture was pre-
adsorbed onto silica gel and purified by column chromatography (5→20% 
acetone/hexane) to provide the bis(oxazoline) ligand L1.31 (418 mg, 80%) as a white 
crystalline solid. Physical and spectral properties were in accordance with those 
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DL-Phenylglycinol (440 mg, 3.21 mmol) was reacted with dimethylmalonyl chloride 
(0.20 mL, 1.54 mmol) in the presence of Et3N (0.64 mL, 4.63 mmol) in CH2Cl2 (10 
mL) by the method previously described
[56]
 to give N,N'-bis[2-(2-hydroxy-1-
phenylethyl)]propanediamide (502 mg, 88%) as an inseparable 3:1 mixture of 
isomers. The crude mixed diamides (502 mg, 1.35 mmol) and (NH4)6Mo7O24·4H2O 
(85 mg, 0.69 mmol, 35 mol% Mo) were suspended in xylenes (40 mL) and the 
mixture was stirred at reflux using a Dean-Stark apparatus for 4 h. TLC analysis 
(25% acetone/hexane) revealed complete consumption of the diamides (Rf 0.00) and 
formation of a major product (Rf 0.20). The reaction mixture was pre-adsorbed onto 
silica gel and purified column chromatography (2→18% acetone/hexane) to separate 
the major component (colourless oil, 249 mg, 55%) from the mixture. NMR data for 









To a solution of di-tert-butyl dicarbonate (50.9 g, 233 mmol) in EtOH (500 mL) at –
10 °C was added 35% NH3 (aq) (50 mL) over 5 min. The reaction mixture was 
stirred vigorously for a further 30 min at –10 °C to 0 °C, and then at room 
temperature for 18 h. The solvents were removed from the resulting thick suspension 
in vacuo at 50 °C to ensure decomposition of ammonium tert-butyl carbonate. The 
residue was suspended in hexane (500 mL), stirred at 60 °C for 1 h, and then 
recrystallised from refluxing hexane (total volume ~650 mL) to provide tert-butyl 
carbamate (25.9 g, 95%) as a white crystalline solid. Physical and spectral properties 
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Following a slightly modified literature procedure,
[52]
 the appropriate aldehyde (15 
mmol) was suspended in 2:1:0.7 H2O/MeOH/HCO2H (40 mL) and stirred until the 
mixture became homogeneous. Gentle heating was necessary to achieve complete 
dissolution in most cases, and addition of additional solvent was required where 
noted. Sodium benzenesulfinate (20 mmol) or sodium 4-methylbenzenesulfinate (20 
mmol) and tert-butyl carbamate (10 mmol) were then added sequentially. The 
reaction mixture was stirred for 3 d, the solids collected by filtration and triturated 
























         







































































































 m.p. 168-170 ºC; IR (film) 3138, 1697 (C=O), 1526 (NO2), 1346 




H NMR (500 MHz, (CD3)2SO at 70 °C*)  
8.65 (1H, br s, NH), 8.09 (2H, t, J = 8.9 Hz, ArH), 7.84 (1H, t, J = 7.8 Hz, ArH), 
7.81-7.65 (6H, m, ArH), 7.21 (1H, d, J = 10.7 Hz, CHN), 1.22 (9H, s, C(CH3)3); 
13
C 
NMR (125.8 MHz, (CD3)2SO at 70 ºC)  148.8 (C), 136.4 (C), 134.0 (CH), 133.1 
(CH), 130.5 (CH), 130.5 (CH), 129.1 (2 x CH), 128.6 (C), 128.4 (2 x CH), 124.6 
(CH), 124.0 (C), 79.6 (C), 68.7 (CH), 27.4 (3 x CH3). *A rotameric mixture 
was observed at room temperature. 
 
tert-Butyl N-[(4-bromophenyl)[(4-methylbenzene)sulfonyl] 
methyl] 1.103h  
m.p. 180-182 ºC; IR (film) 2961, 1694 (C=O), 1503, 1487, 1304 




H NMR (500 MHz, CDCl3)  7.78 
(2H, d, J = 8.0 Hz, ArH), 7.57-7.52 (2H, m, ArH), 7.34 (2H, d, J = 8.0 Hz, ArH), 
7.32 (2H, d, J = 8.5 Hz, ArH), 5.86 (1H, d, J = 10.4 Hz, CHN), 5.75 (1H, d, J = 10.4 
Hz, NH), 2.44 (3H, s, ArCH3), 1.27 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, 
CDCl3)  153.4 (C), 145.3 (C), 131.9 (2 x CH), 130.4 (2 x CH), 129.8 (2 x CH), 




carbamate 1.103i.  
m.p. 140-142 ºC; IR (film) 2959, 1697 (C=O), 1585, 1504, 1312 




H NMR (500 MHz, CDCl3)  
7.92 (2H, d, J = 7.5 Hz, ArH), 7.65 (1H, t, J = 7.4 Hz ArH), 7.54 (2H, d, J = 7.7 Hz, 
ArH), 7.33 (1H, d, J = 8.1 Hz, ArH), 7.03 (1H, d, J = 7.5 Hz, ArH), 7.00-6.94 (2H, 
m, ArH), 5.90 (1H, d, J = 10.5 Hz, CHN), 5.79 (1H, d, J = 10.5 Hz, NH), 3.81 (3H, 
s, OCH3), 1.27 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  159.7 (C), 153.4 
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A suspension of flame-dried Cs2CO3 (6.0 mmol) in a solution of the appropriate 
sulfonylcarbamate (2.0 mmol) in dry, alcohol-free CH2Cl2 (40 mL) was heated at 
reflux. Small aliquots were removed periodically, filtered, and analysed by 
1
H NMR 
spectroscopy (using CDCl3 treated with K2CO3 to remove trace HCl which 
hydrolyzes the N-Boc imine) to confirm completion of the reaction (1–4 h). The 
reaction mixture was cooled to room temperature, diluted with hexane (40 mL), 
stirred for 10 min, and filtered. The filtrate was concentrated in vacuo at <20 °C to 
leave the N-Boc imine (90–100%). Data for imines 1.83a Ar = Ph,
[52]
 1.83b Ar = p-
NCC6H4,
[54]
 1.83c Ar = p-O2NC6H4,
[55]
 1.83d Ar = p-MeC6H4,
[52]
 1.83e Ar = m-
ClC6H4,
[60]
 1.83f Ar = o-O2NC6H4,
[61]
 1.83g Ar = m-O2NC6H4,
[52]
 1.83h Ar = p-
BrC6H4,
[54]
 and 1.83i Ar = m-MeOC6H4,
[62]
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A mixture of 2-amino-5-nitrophenol (5.0 g, 32 mmol) and triethyl orthoacetate (23.6 
mL, 129 mmol) was stirred at 100 °C for 2 hours, cooled to room temperature and 
the precipitate was collected by filtration and washed with hexane (2 x 25 mL). 
Purification of the residue by column chromatography (50→80% DCM/hexane) gave 
the benzoxazole 1.85a (5.22 g, 90%) as a white solid. Rf 0.30 (20% acetone/hexane); 
m.p. = 150-152 °C; IR (film) 3073, 1614, 1576, 1520 (NO2), 1463, 1438,  1350 
(NO2), 1269, 1173, 911; 
1
H NMR (500 MHz, CDCl3)  8.41 (1H, d, J = 1.8 Hz, 
ArH); 8.29 (1H, dd, J = 8.7, 2.2 Hz, ArH), 7.76 (1H, dd, J = 8.7 Hz, ArH), 2.74 (3H, 
s, CH3); 
13
C NMR (125.8 MHz, CDCl3)  168.8 (C), 150.1 (C), 146.8 (C), 145.0 (C), 
120.4 (CH), 119.4 (CH), 106.9 (CH), 14.9 (CH3). Physical and spectral properties 







A mixture of 2-amino-5-nitrophenol (5.00 g, 32.0 mmol) and triethyl orthopropionate 
(7.1 mL, 35 mmol) was stirred at 100 °C for 2 h, cooled to room temperature, and the 
precipitate was collected by filtration. Recrystallisation of the precipitate 
(EtOH/water) afforded the benzoxazole 1.85b (2.80 g, 44%) as a pale brown 
crystalline solid. Rf 0.67 (2% MeOH/DCM); m.p. 82-84°C; IR (film) 2932, 1569, 
1513 (NO2), 1458, 1420, 1336 (NO2), 1229, 1151, 1055, 735; 
1
H NMR (500 MHz, 
CDCl3)  8.40 (1H, d, J = 1.9 Hz, ArH), 8.29 (1H, dd, J = 8.7, 2.2 Hz, ArH), 7.77 








C NMR (125.8 MHz, CDCl3)  173.0 (C), 150.0 (C), 146.7 (C), 144.9 
(C), 120.3 (CH), 119.4 (CH), 106.9 (CH), 22.4 (CH2), 10.6 (CH3). Physical and 





A mixture of 2-amino-5-nitrophenol (1.80 g, 12.0 mmol) and trimethyl orthobutyrate 
(3.9 mL, 24 mmol) was stirred at 100 °C for 2 h, cooled to room temperature, and 
concentrated in vacuo. Purification of the residue by column chromatography 
(0→3% acetone/toluene) gave the benzoxazole 1.85c (2.29 g, 93%) as a pale yellow 
solid. Rf 0.55 (5% acetone/toluene); m.p. 48-50 °C; IR (film) 1570, 1517 (NO2), 




H NMR (500 MHz, CDCl3) 
 8.40 (1H, d, J = 2.1 Hz, ArH), 8.29 (1H, dd, J = 8.7, 2.1 Hz, ArH), 7.77 (1H, d, J = 
8.7 Hz, ArH), 3.00 (2H, t, J = 7.5 Hz, CH2CH2CH3), 2.00-1.93 (2H, m, CH2CH3), 
1.09 (3H, t, J = 7.4 Hz, CH3); 
13
C NMR (125.8 MHz, CDCl3)  172.1 (C), 149.9 (C), 
146.7 (C), 144.9 (C), 120.3 (CH), 119.4(CH), 106.9 (CH), 30.7 (CH2), 20.0 (CH2), 
13.7 (CH3); HRMS (ESI +ve) Exact mass calculated for C10H11N2O3 [M+H]
+
: 
207.0764, found: 207.0763. 
2-Butyl-6-nitrobenzoxazole (1.85d) 
 
A mixture of 2-amino-5-nitrophenol (2.50 g, 16.0 mmol) and trimethyl orthovalerate 
(5.8 mL, 33 mmol) was stirred at 100 °C for 2 h, cooled to room temperature, and 
concentrated in vacuo. Purification of the residue by column chromatography 
(0→3% acetone/toluene) gave the benzoxazole 1.85d (3.13 g, 89%) as a pale yellow 
solid. Rf 0.60 (5% acetone/toluene); m.p. 26-28 °C; IR (film) 2960, 2872, 1618, 
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CDCl3)  8.41 (1H, d, J = 2.1 Hz, ArH), 8.30 (1H, dd, J = 8.7, 2.2 Hz, ArH), 7.78 
(1H, d, J = 8.7 Hz, ArH), 3.03 (2H, t, J = 7.6 Hz, CH2CH2CH2CH3), 1.96-1.90 (2H, 
m, CH2CH2CH3), 1.54-1.46 (2H, m, CH2CH3), 1.02 (3H, t, J = 7.4 Hz, CH3); 
13
C 
NMR (125.8 MHz, CDCl3)  172.3 (C), 149.9 (C), 146.7 (C), 144.9 (C), 120.3 (CH), 
119.4 (CH), 106.9 (CH), 28.5 (2 x CH2), 22.2 (CH2), 13.6 (CH3); HRMS (ESI +ve) 
Exact mass calculated for C11H13N2O3 [M+H]
+





To a vigorously stirring mixture of methoxyacetonitrile (1.00 mL, 13.5 mmol) and 
EtOH (0.85 mL, 14.6 mmol) was added anhydrous HCl (2 M in Et2O, 7.5 mL, 14 
mmol) at RT. After 16 h the precipitate was collected by filtration, washed with 
Et2O, and dried in vacuo to leave the imidate salt (1.51 g, 73%) as a white solid. 






A solution of 2-amino-5-nitrophenol (333 mg, 2.16 mmol) and ethyl 2-
methoxyacetimidate hydrochloride (500 mg, 3.28 mmol) in EtOH (2 mL) was stirred 
at reflux for 2 h. After cooling to room temperature, the reaction mixture was diluted 
with EtOAc (10 mL), washed sequentially with 1:1 brine/saturated aqueous NaHCO3 
solution (2 x 10 mL), and brine (10 mL). The organic layer was dried (MgSO4), 
filtered, and concentrated in vacuo. Purification of the residue by column 
chromatography (0→6% acetone/toluene) gave the benzoxazole 1.85e (411 mg, 
91%) as a white crystalline solid. Rf 0.35 (5% acetone/toluene); m.p. 86-88 °C; IR 




H NMR (500 MHz, CDCl3)  8.41 (1H, d, J = 2.2 Hz, ArH), 8.27 (1H, dd, J = 8.8, 




THE UNIVERSITY of EDINBURGH 
 
13
C NMR (125.8 MHz, CDCl3)  167.3 (C), 149.8 (C), 145.9 (C), 145.4 (C), 120.5 
(CH), 120.2 (CH), 107.3 (CH), 66.7 (CH2), 59.5 (CH3); HRMS (ESI +ve) Exact 
mass calculated for C9H9N2O4 [M+H]
+
: 209.0557, found: 209.0554. 
7-Nitro-1H,2H,3H,9H-pyrrolo[2,1-b]quinazolin-9-one (1.88) 
 
To a mixture of 2-amino-5-nitrobenzoic acid (2.00 g, 11.0 mmol) and 2-
pyrrolidinone (1.10 mL, 16.0 mmol), phosphoryl chloride (3.60 mL, 14.0 mmol) was 
added and the mixture was stirred at 100 °C for 1 h. The reaction mixture was cooled 
to 0 °C, diluted with water (10 mL), made alkaline with conc. ammonia solution, and 
extracted with chloroform (3 x 10 mL). The organic layer was collected, dried over 
MgSO4 and concentrated in vacuo. Purification of the residue by column 
chromatography (50→80% EtOAc/hexane) gave the quinazolin-9-one 1.88 (1.23 g, 
47%) as a yellow solid. Rf 0.64 (2% EtOAc/hexane); m.p. 188-190 °C; IR (film) 
2927, 1689, 1601, 1569, 1515 (NO2), 1388 (NO2), 1331, 1252, 857, 670; 
1
H NMR 
(500 MHz, CDCl3)  9.14 (1H, d, J = 2.6 Hz, ArH), 8.51 (1H, dd, J = 9.0, 2.7 Hz, 
ArH), 7.7 (1H, d, J = 9.0 Hz, ArH), 4.28-4.25 (2H, m, CH2), 3.25 (2H, t, J = 8.0 Hz, 
CH2), 2.39-2.33 (2H, m, CH2); 
13
C NMR (125.8 MHz, CDCl3)  163.2 (C), 159.8 
(C), 153.3 (C), 145.3 (C), 128.4 (C), 128.3 (2 x CH), 123.1 (CH), 46.9 (CH2), 32.9 
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Preparation of racemic products:  
2-(6-nitro-1,3-benzoxazole-2-yl)-1-(4-nitrophenyl)ethan-1-
ol (1.93a).  
A mixture of rac-BINAP (30.0 mg, 0.05 mmol) and AgOAc 
(8.00 mg, 0.05 mmol) in THF (2 mL) was stirred at room temperature for 15 min. 
1,3-Benzoxazole 1.85a (71.0 mg, 0.40 mmol) and p-nitrobenzaldehyde 1.92a. (46.0 
mg, 0.40 mmol) were added and the reaction mixture was stirred at room temperature 
for 48 h. The mixture was filtered through a short plug of SiO2, eluted with EtOAc 
and concentrated in vacuo. Purification of the residue by column chromatography 
(10→80%  EtOAc/petroleum ether) gave the addition product 1.93a as a white 
crystalline solid (49 mg, 37%). Rf 0.39 (40% EtOAc/petroleum ether); m.p. 171-172 




H NMR (400 MHz, (CD3)2SO)  8.64 (1H, d, J = 1.9 Hz, ArH), 8.27 (1H, dd, J = 
8.8, 2.2 Hz, ArH), 8.23-8.18 (2H, m, ArH), 7.91 (1H, dd, J = 6.5, 2.5 Hz,  ArH), 
7.75-7.70 (2H, m, ArH), 6.10 (1H, d, J = 4.8 Hz, OH), 5.37 (1H, app dt, J = 9.7, 4.7 
Hz, CH), 3.48 (1H, dd, J = 15.1, 4.6 Hz, CH2), 3.39-3.30 (1H, m, CH2); 
13
C NMR 
(101 MHz, (CD3)2SO) δ 169.4 (C), 151.7 (C), 149.5 (C), 146.8 (C), 146.3 (C), 144.6 
(C), 127.2 (2 x CH), 123.4 (2 x CH), 120.5 (CH), 119.6 (CH), 107.3 (CH), 69.6 
(CH), 38.2 (CH2) HRMS (ESI +ve) Exact mass calculated for C15H12N3O6 [M+H]
+
: 
330.0721, found: 330.0714; Exact mass calculated for C15H11N3NaO6 [M+Na]
+
: 
352.0540, found: 352.0528. 
2-(6-nitro-1,3-benzoxazole-2-yl)-1-(4-
nitrophenyl)propan-1-ol (1.93.b).  
A soulution of rac-BINAP (30.0 mg, 0.05 mmol) and 
AgOAc (8.00 mg, 0.05 mmol) in THF (2 mL) was 
stirred at room temperature for 15 min. 1,3-Benzoxazole 1.85b (77.0 mg, 0.40 mmol) 
and p-nitrobenzaldehyde 1.92a (46.0 mg, 0.40 mmol) were added and the reaction 
mixture was stirred at room temperature for 48 h. The mixture was filtered through a 
short plug of SiO2, eluted with EtOAc and concentrated in vacuo. The crude product 
was obtained as a diastereomeric mixture in a 1:1 A:B ratio. Purification of the 
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addition product 1.93b as a white crystalline solid (42 mg, 31%). Rf 0.48 (40% 
EtOAc/petroleum ether); m.p. 187-188 ºC; IR (film) 1566, 1513 (NO2), 1345 (NO2), 
1233, 1309, 827, 735, 640 cm
-1
; The purified product was obtained as a 
diastereomeric mixture in a 1:1.4 A:B ratio. 
1
H NMR (400 MHz, (CD3)2SO)  8.66-
8.63 (2H, m, ArH
A+B
), 8.30-8.25 (2H, m, ArH
A+B
), 8.22-8.16 (4H, m, ArH
A+B
), 7.95-
7.90 (2H, m, ArH
A+B
), 7.68-7.61 (4H, m, ArH
A+B
), 6.09 (1H, d, J = 4.6 Hz, OH
A
), 
6.04 (1H, d, J = 4.6 Hz, OH
B
), 5.35 (1H, t, J = 4.8 Hz, CH
B
), 5.09 (1H, dd, J = 7.4, 
4.6 Hz, CH
A
) 3.69-3.61 (1H, m, CH
B
), 3.56 (1H, m, J = 7.1 Hz, CH
A
), 1.29 (3H, d, J 
= 7.0 Hz, CH3
B



































), 123.3 (2 x CH
A


























 ), 11.4 (CH3
B
); Exact mass calculated for C16H14N3O6 
[M+H]
+
: 344.0877, found: 366.0858.Exact mass calculated for C16H13N3NaO6 
[M+Na]
+




A mixture of rac-BINAP (30.0 mg, 0.05 mmol) and AgOAc (8.00 mg, 0.05 mmol) in 
THF (2 mL) was stirred at room temperature for 15 min. 1,3-benzoxazole 1.85c (82.0 
mg, 0.40 mmol) and N-sulfamoyl imine 1.97a (85.0 mg, 0.04 mmol) were added and 
the reaction was stirred at room temperature for 24 h. The mixture was filtered 
through a short plug of SiO2, eluted with EtOAc and concentrated in vacuo. 
Purification of the residue by column chromatography (1→ 2% MeOH/DCM) gave 
the addition product 1.98c (85.7mg, 51%) as a yellow oil. Rf 0.16 (1% 
MeOH/DCM). The desired product was obtained as a diastereomeric mixture in a 
73:27 ratio A:B. 
1
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(1H, d, J = 2.1 Hz, ArH
A
), 8.31 (1H, dd, J = 8.8, 2.1 Hz, ArH
B
), 8.26 (1H, dd, J = 
8.8, 2.1 Hz, ArH
A
), 7.82 (1H, d, J = 8.8 Hz, ArH
B
) 7.73 (1H, d, J = 8.7 Hz, ArH
A
), 
7.31-7.10 (10H, m, ArH
A+B
), 6.13 (1H, 1d, J = 9.1 Hz, NHSO2
B
), 5.77 (1H, d, J = 
9.0 Hz, NHSO2
A




3.48 (1H, ddd, J = 10.0, 7.4, 4.7 
Hz, CH
A
CH2CH3), 3.35 (1H, ddd, J = 9.7, 6.3, 5.6 Hz, CH
B
CH2CH3), 2.51 (6H, s, 
N(CH3)2
A
), 2.47 (6H, s, N(CH3)2
B




), 1.93-1.83 (1H, 
m, CH2
B


























), 128.8 (2 x CH
B







), 126.7 (2 x CH
A





















), 38.3 (2 
x CH3
B






), 11.9 (2 x CH3). 




A mixture of (S)-DM-SEGPHOS (43.0 mg, 0.06 mmol) and Pd(OAc)2 (13.0 mg, 
0.06 mmol) in THF (2.5 mL) was stirred at room temperature for 15 min. 1,3-
benzoxazole 1.85c (103 mg, 0.50 mmol) and N-sulfamoyl imine 1.97a (106 mg, 0.50 
mmol) were added and the reaction was stirred at room temperature for 24 h. The 
mixture was filtered through a short plug of SiO2, eluted with EtOAc and 
concentrated in vacuo. Purification of the residue by column chromatography (1→ 
2% MeOH/DCM) gave the addition product 1.98c (108 mg, 52%) as a yellow oil. Rf 
0.16 (1% MeOH/DCM). The desired product was obtained as a diastereomeric 
mixture in a >19:1 ratio. 
1
H NMR (500 MHz, CDCl3)  8.37 (1H, d, J = 2.0 Hz, 
ArH); 8.32 (1H, dd, J = 8.8, 2.1 Hz, ArH), 7.83 (1H, d, J = 8.8 Hz, ArH), 7.33-7.24 
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dd, J = 8.9, 6.1 Hz, PhCHNH), 3.33 (1H, dt, J = 9.4, 5.8 Hz, CCHCHPh), 2.50 (6H, 
s, N(CH3)2), 2.12-2.00 (1H, m, CH2), 2.00-1.86 (1H, m, CH2) , 0.97 (3, t, J = 7.44 
Hz, CH3); 
13
C NMR (125.8 MHz, CDCl3)  171.5 (C), 149.4 (C), 145.8 (C), 145.2 
(C), 140.4 (C), 128.9 (2 x CH), 128.2 (CH), 126.3 (2 x CH), 120.7 (CH), 119.8 (CH), 
107.3 (CH), 59.6 (CH), 49.3 (CH), 37.6 (CH2), 25.4 (CH2), 11.9 (2 x CH3). 
Pd(II)-Catalysed addition reactions to imines 
General Procedure A 
 
To a mixture of the appropriate alkylazaarene (0.50 mmol) and the appropriate N-
Boc imine (0.75 mmol) at room temperature was added a solution of Pd(OAc)2 (5.5 
mg, 25 mol) and ligand L1.31 (12.2 mg, 25.1 mol) in CHCl3 (0.5 mL, alcohol-
free, amylene-stabilized). The reaction mixture was stirred at room temperature 
temperature for 24 h, filtered through a short plug of silica gel using 30% 
acetone/hexane as eluent, and concentrated in vacuo. Purification of the residue by 
column chromatography gave the addition product as a single diastereoisomer. 
 
tert-Butyl N-[(1R,2S)-1-(4-cyanophenyl)-2-(6-nitro-
1,3-benzoxazol-2-yl)butyl]carbamate (1.107b).  
The title compound was prepared according to General 
Procedure A from alkylazaarene 1.85c (103 mg, 0.50 mmol) and N-Boc imine 1.83b 
(173 mg, 0.75 mmol) and purified by column chromatography (2→12% 
acetone/hexane) to give a white solid (189 mg, 87%). Rf 0.17 (20% acetone/hexane); 
m.p. 86-88 °C; [α] +32 (c 1.01, CHCl3); IR (film) 2230 (C≡N), 1713 (C=O), 1562, 




H NMR (500 MHz, 
CD3OD) δ 8.54 (1H, d, J = 1.9 Hz, ArH), 8.33 (1H, dd, J = 8.8, 1.9 Hz, ArH), 7.87 
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ArH), 5.17 (1H, d, J = 8.8 Hz, CHN), 3.53 (1H, ddd, J = 9.8, 9.7, 4.6 Hz, 
CHCH2CH3), 1.95-1.80 (1H, m, CH2CH3), 1.66-1.53 (1H, m, CH2CH3), 1.24 (9H, s, 
C(CH3)3), 0.84 (3H, t, J = 7.4 Hz, CH2CH3); 
13
C NMR (125.8 MHz, CD3OD)  
173.3 (C), 157.1 (C), 151.2 (C), 147.4 (C), 147.3 (C), 146.7 (C), 133.7 (2 x CH), 
129.3 (2 x CH), 121.6 (CH), 120.8 (CH), 119.4 (C), 112.7 (C), 108.3 (CH), 80.7 (C), 
58.3 (CH), 49.1 (CH), 28.5 (3 x CH3), 25.5 (CH2), 11.9 (CH3); HRMS (ESI +ve) 
Exact mass calculated for C23H25N4O5 [M+H]
+
: 437.1820, found: 437.1826. 
Enantiomeric excess was determined by HPLC with a Chiralpak IA-3 column (90:10 
hexane:EtOH, 2.0 mL/min, 230 nm, 25 °C); tr (major) = 9.2 min, tr (minor) = 12.9 
min; 87% ee. 
 
tert-Butyl N-[(1R,2S)-2-(6-nitro-1,3-benzoxazol-2-
yl)-1-(4-nitrophenyl)butyl]carbamate (1.107c).  
The title compound was prepared according to General 
Procedure A from alkylazaarene 1.85c (103 mg, 0.50 mmol) and N-Boc imine 1.83c 
(188 mg, 0.75 mmol) and purified by column chromatography (2→12% 
acetone/hexane) to give a white solid (213 mg, 93%). Rf 0.17 (20% acetone/hexane); 
m.p. 82-84 °C; [α] +27 (c 1.01, CHCl3);
 
 IR (film) 1711 (C=O), 1564, 1522 (NO2), 




H NMR (500 MHz, CD3OD) δ 
8.53 (1H, d, J = 2.0 Hz, ArH), 8.33 (1H, dd, J = 8.8, 2.0 Hz, ArH), 8.22 (2H, d, J = 
8.5 Hz, ArH), 7.87 (1H, d, J = 8.8 Hz, ArH), 7.63 (2H, d, J = 8.7 Hz, ArH), 5.23 
(1H, d, J = 8.7 Hz, CHN), 3.56 (1H, ddd, J = 9.8, 9.7, 4.6 Hz, CHCH2CH3), 1.96-
1.83 (1H, m, CH2CH3), 1.67-1.56 (1H, m, CH2CH3), 1.25 (9H, s, C(CH3)3), 0.85 
(3H, t, J = 7.4 Hz, CH2CH3); 
13
C NMR (125.8 MHz, CD3OD)  173.2 (C), 157.1 
(C), 151.2 (C), 149.2 (C), 148.9 (C), 147.3 (C), 146.7 (C), 129.4 (2 x CH), 124.8 (2 x 
CH), 121.6 (CH), 120.8 (CH), 108.3 (CH), 80.8 (C), 58.0 (CH), 49.2 (CH) 28.5 (3 x 
CH3), 25.5 (CH2), 11.9 (CH3); HRMS (ESI +ve) Exact mass calculated for 
C22H25N4O7 [M+H]
+
: 457.1718, found: 457.1718. Enantiomeric excess was 
determined by HPLC with a Chiralpak IA-3 column (80:20 hexane:i-PrOH, 2.0 
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tert-Butyl N-[(1R,2S)-1-(4-methylphenyl)-2-(6-nitro-
1,3-benzoxazol-2-yl)pentyl]carbamate (1.107d).  
The title compound was prepared according to General 
Procedure A from alkylazaarene 1.85d (110 mg, 0.50 mmol) and N-Boc imine 1.83d 
(164 mg, 0.75 mmol) and purified by column chromatography (2→12% 
acetone/hexane) to give a white solid (190 mg, 86%). Rf 0.34 (20% acetone/hexane); 
m.p. 58-60 ºC; [α] +31 (c 1.05, CHCl3); IR (film) 1718 (C=O), 1602, 1577, 1520 




H NMR (500 MHz, CD3OD) δ 
8.53 (1H, d, J = 1.9 Hz, ArH), 8.32 (1H, dd, J = 8.7, 1.8 Hz, ArH), 7.85 (1H, d, J = 
8.8 Hz, ArH), 7.23 (2H, d, J = 8.0 Hz, ArH), 7.16 (2H, d, J = 7.9 Hz, ArH), 4.99 
(1H, d, J = 9.3 Hz, CHN), 3.53 (1H, ddd, J = 10.7, 9.7, 4.2 Hz, CHCH2CH2CH3), 
2.32 (3H, s, ArCH3), 1.91-1.76 (1H, m, CH2CH2CH3), 1.50-1.42  (1H, m, 
CH2CH2CH3), 1.27-1.13 (2H, m, CH2CH3), 1.19 (9H, s, C(CH3)3), 0.80 (3H, t, J = 
7.3 Hz, CH2CH3); 
13
C NMR (125.8 MHz, CD3OD) δ 174.3 (C), 157.1 (C), 151.2 (C), 
147.4 (C), 146.6 (C), 138.8 (C), 138.7 (C), 130.4 (2 x CH), 128.1 (2 x CH), 121.5 
(CH), 120.6 (CH), 108.3 (CH), 80.3 (C), 58.7 (CH), 48.0 (CH), 58.7 (CH), 34.3 
(CH2), 28.5 (3 x CH3), 21.5 (CH2), 21.1 (CH3), 13.9 (CH3); HRMS (ESI +ve) Exact 
mass calculated for C24H30N3O5 [M+H]
+
: 440.2180, found: 440.2180. Enantiomeric 
excess was determined by HPLC with a Chiralpak IA-3 column (80:20 hexane:i-




chlorophenyl)pentyl]carbamate (1.107e).  
The title compound was prepared according to a slight 
modification of General Procedure A (in that the reaction temperature was 60 °C) 
from alkylazaarene 1.85d (110 mg, 0.50 mmol) and N-Boc imine 1.85e (180 mg, 
0.75 mmol) and purified by column chromatography (2→12% acetone/hexane) to 
give a 96:4 inseparable mixture of diastereomers as a white solid (190 mg, 83%). Rf 
0.26 (20% acetone/hexane); m.p. 58-60 °C; [α] +23 (c 1.05, CHCl3); IR (film) 















H NMR (500 MHz, CD3OD) δ 8.49 (1H, d, J = 2.1 Hz, ArH), 
8.29 (1H, dd, J = 8.8, 2.1 Hz, ArH), 7.84 (1H, d, J = 8.8 Hz, ArH), 7.46-7.37 (1H, m, 
ArH), 7.35-7.25 (3H, m, ArH), 5.07 (1H, d, J = 9.1 Hz, CHN), 3.57 (1H, ddd,  J =  
10.5, 9.3, 4.3 Hz, CHCH2CH2CH3), 1.92-1.79 (1H, m, CH2CH2CH3), 1.52-1.42 (1H, 
m, CH2CH2CH3), 1.30-1.15 (CH2CH3), 1.21 (9H, s, C(CH3)3), 0.80 (3H, t, J = 7.3 
Hz, CH2CH3); 
13
C NMR (125.8 MHz, CD3OD)  173.8 (C), 157.1 (C), 151.1 (C), 
147.3 (C), 146.7 (C), 144.2 (C), 135.7 (C), 131.3 (CH), 129.0 (CH), 128.3 (CH), 
126.7 (CH), 121.6 (CH), 120.7 (CH), 108.3 (CH), 80.6 (C), 58.4 (CH), 47.6 (CH), 
34.3 (CH2), 28.5 (3 x CH3), 21.5 (CH2), 13.9 (CH3).  
Minor diastereomer (diagnostic peaks): 
1
H NMR (500 MHz, CD3OD)
 
δ 8.43 (1H, d, 
J = 2.1 Hz, ArH), 8.23 (2H, dd, J = 8.8, 2.1 Hz, ArH), 7.72 (1H, d, J = 8.8 Hz, ArH), 
7.18-7.08 (3H, m, ArH), 2.08-1.98 (1H, m, CH2CH2CH3). 
HRMS (ESI +ve) Exact mass calculated for C23H27ClN3O5 [M+H]
+
: 460.1634, 
found: 460.1633. Enantiomeric excess was determined by HPLC with a Chiralpak 
IA-3 column (80:20 hexane:i-PrOH, 2.0 mL/min, 230 nm, 25 °C); tr (major) = 3.6 
min, tr (minor) = 6.8 min; 89% ee. 
tert-Butyl N-[(1R,2S)-2-(1,3-benzoxazol-2-yl)-1-(2-
nitrophenyl)pentyl]carbamate (1.107f).  
The title compound was prepared according to a 
modification of General Procedure A (in that the reaction 
temperature was 50 °C) from alkylazaarene 1.85d (110 mg, 0.50 mmol) and N-Boc 
imine 1.83f (188 mg, 0.75 mmol) and purified by column chromatography (2→12% 
acetone/hexane) to give a white solid (165 mg, 70%). Rf 0.23 (20% acetone/hexane); 
m.p. 86-88°C; [α] –27 (c 0.98, CHCl3); IR (film) 2974, 1701 (C=O), 1564, 1530 




H NMR (500 MHz, 
CD3OD) δ 8.44 (1H, br s, ArH), 8.26 (1H, dd, J = 8.8, 2.2 Hz, ArH), 7.75-7.60 (4H, 
m, ArH), 7.39 (1H, t, J = 8.0 Hz, ArH), 5.82 (1H, d, J = 8.6 Hz, CHN), 3.69-3.60 
(1H, m, CHCH2CH2CH3), 2.17-2.04 (1H, m, CH2CH2CH3), 1.98-1.90 (1H, m, 
CH2CH2CH3), 1.42-1.19 (2H, m, CH2CH3), 1.38 (9H, s, C(CH3)3), 0.90 (3H, t, J = 
7.3 Hz, CH2CH3); 
13
C NMR (125.8 MHz, CD3OD)  172.7 (C), 157.4 (C), 151.1 
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125.4 (CH), 121.5 (CH), 120.7 (CH), 108.2 (CH), 80.8 (C), 53.7 (CH), 47.3 (CH), 
32.4 (CH2), 28.6 (3 x CH3), 21.6 (CH2), 14.1 (CH3); HRMS (ESI +ve) Exact mass 
calculated for C23H27N4O7 [M+H]
+
: 471.1874, found: 471.1875. Enantiomeric excess 
was determined by HPLC with a Chiralpak IA-3 column (90:10 hexane:i-PrOH, 2.0 




The title compound was prepared according to a modification of General Procedure 
A (in that the reaction temperature was 50 °C) from alkylazaarene 1.85g (117 mg, 
0.50 mmol) and N-Boc imine 1.83g (188 mg, 0.75 mmol) and purified by column 
chromatography (2→12% acetone/hexane) to give a white solid (194 mg, 87%). Rf 
0.22 (20% acetone/hexane); m.p. 62-64 ºC; [α]
20
D +24 (c 1.0, CHCl3); IR (film) 2960, 





NMR (500 MHz, CD3OD) δ 8.29 (1H, t, J = 1.9 Hz, ArH), 8.22 (1H, d, J = 0.7 Hz, 
ArH), 8.19-8.15 (1H, br d, ArH), 8.08 (1H, dd, J = 8.3, 0.9 Hz, ArH), 7.77 (2H, t, J 
= 8.8 Hz, ArH), 7.61 (1H, t, J = 7.9 Hz, ArH), 5.21 (1H, d, J = 8.9 Hz, CHN), 3.95 
(3H, s, OCH3), 3.62 (1H, ddd, J = 10.7, 9.0, 4.4 Hz, CHCH2CH2CH3), 1.95-1.83 
(1H, m, CH2CH2CH3), 1.55-1.42 (1H, m, CH2CH2CH3), 1.29-1.16 (2H, m, 
CH2CH3), 1.23 (9H, s, C(CH3)3), 0.82 (3H, t, J = 7.3 Hz, CH2CH3); 
13
C NMR 
(125.8 MHz, CD3OD)  171.5 (C), 167.9 (C), 157.2 (C), 151.6 (C), 149.9 (C), 145.9 
(C), 144.4 (C), 134.6 (CH), 131.0 (CH), 128.5 (C), 127.3 (CH), 123.7 (CH), 123.0 
(CH), 120.3 (CH), 113.2 (CH), 80.7 (C), 58.2 (CH), 52.9 (CH3), 47.3 (CH), 34.4 
(CH2), 28.4 (3 x CH3), 21.5 (CH2), 13.9 (CH3); HRMS (ESI +ve) Exact mass 
calculated for C25H30N3O7 [M+H]
+
: 484.2078, found: 484.2073. Enantiomeric excess 
was determined by HPLC with a Chiralpak IA-3 column (60:40 hexane:i-PrOH, 1.0 
mL/min, 254 nm, 25 °C); tr (major) = 6.5 min, tr (minor) = 8.5 min; 88% ee. 
 
tert-Butyl N-[(1R,2S)-2-(6-cyano-1,3-benzoxazol-2-
yl)-1-(4-nitrophenyl)pentyl]carbamate (1.107h).  




THE UNIVERSITY of EDINBURGH 
 
modification of General Procedure A (in that the reaction temperature was 50 °C) 
from alkylazaarene 1.85h (100 mg, 0.50 mmol) and N-Boc imine 1.83c (188 mg, 
0.75 mmol) and purified by column chromatography (2→12% acetone/hexane) to 
give a white solid (222 mg, 99%). Rf 0.20 (20% acetone/hexane); m.p. 60-62 ºC; [α]
20
D +29 (c 1.02, CHCl3);
 
IR (film) 2968, 2232 (CN), 1711 (C=O), 1604, 1524 (NO2), 




H NMR (500 MHz, CD3OD) δ 
8.23 (2H, d, J = 8.6 Hz, ArH), 8.07 (1H, s, ArH), 7.85 (1H, d, J = 8.2 Hz, ArH), 7.73 
(1H, d, J = 8.3 Hz, ArH), 7.64-7.60 (2H, m, ArH), 5.20 (1H, d, J = 8.8 Hz, CHN), 
3.56 (1H, td, J = 10.2, 4.4 Hz, CHCH2CH2CH3), 1.94-1.81 (1H, m, CH2CH2CH3), 
1.53-1.44 (1H, m, CH2CH2CH3), 1.32-1.13 (2H, m, CH2CH3), 1.24 (9H, s, C(CH3)3), 
0.82 (3H, t, J = 7.3 Hz, CH2CH3); 
13
C NMR (125.8 MHz, CD3OD)  171.9 (C), 
157.1 (C), 151.3 (C), 149.3 (C), 148.9 (C), 145.9 (C), 130.0 (CH), 129.4 (2 x CH), 
124.9 (2 x CH), 121.8 (CH), 119.5 (C), 116.4 (CH), 109.5 (C), 80.8 (C), 58.3 (CH), 
47.2 (CH), 34.3 (CH2), 28.4 (3 x CH3), 21.5 (CH2), 13.9 (CH3); HRMS (ESI +ve) 
Exact mass calculated for C24H27N4O5 [M+H]
+
: 451.1976, found: 451.1975. 
Enantiomeric excess was determined by HPLC with a Chiralpak IA-3 column (85:15 
hexane:EtOH, 2.0 mL/min, 254 nm, 25 °C); tr (major) = 6.4 min, tr (minor) = 8.9 









The title compound was prepared according to a slight 
modification of General Procedure A (in that the reaction temperature was 50 °C) 
from alkylazaarene 1.91b (114 mg, 0.50 mmol) and N-Boc imine 1.83b (213 mg, 
0.75 mmol) and purified by column chromatography (2→12% acetone/hexane) to 
give a white crystalline solid (215 mg, 84%). Rf 0.37 (20% acetone/hexane), m.p. 70-
72 ºC; [α]
20
D +14 (c 1.02, CHCl3);
 
 IR (film) 1709 (C=O), 1599, 1578, 1524 (NO2), 




H NMR (500 MHz, CDCl3) δ 9.46 
(1H, s, ArH), 8.08 (1H, d, J = 7.0 Hz, ArH), 7.31-7.27 (2H, m, ArH), 7.24-7.13 (3H, 
m, ArH), 6.99 (2H, d, J = 6.0 Hz, ArH), 6.89 (2H, d, J = 7.7 Hz, ArH), 6.58 (1H, d, J 
= 8.2 Hz, ArH), 5.12 (1H, br s, CHN), 3.48 (1H, br s, CHCH2Ph), 3.24-3.17 (2H, m, 
CH2Ph), 1.47 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  167.4 (C), 155.4 
(C), 144.4 (CH), 142.9 (C), 140.8 (C), 138.5 (C), 131.4 (CH), 131.0 (CH), 128.8 (2 x 
CH), 128.6 (2 x CH), 127.6 (2 x CH), 126.6 (2 x CH), 125.2 (CH), 120.9 (C), 79.8 
(C), 57.0 (CH), 55.0 (CH), 39.5 (CH2), 28.4 (3 x CH3); HRMS (ESI +ve) Exact mass 
calculated for C25H26BrN3NaO4 [M+Na]
+
: 534.0999, found: 534.0992. Enantiomeric 
excess was determined by HPLC with a Chiralpak IA-3 column (90:10 
hexane:EtOH, 2.0 mL/min, 230 nm, 25 °C); major diastereoisomer: tr (major) = 4.3 




 The title compound was prepared according to a slight 
modification of General Procedure A (in that the reaction temperature was 50 °C) 
from alkylazaarene 1.91b (114 mg, 0.50 mmol) and N-Boc imine 1.83b (173 mg, 
0.75 mmol) and purified by column chromatography (2→12% acetone/hexane) to 
give a white crystalline solid (190 mg, 80%). Rf 0.13 (20% acetone/hexane); m.p. 
208-210 ºC; [α]
20
D +1.0 (c 1.03, (CH3)2CO);
 
IR (film) 3367 (NH), 2229 (C≡N), 1711 




H NMR (500 
MHz, (CD3)2SO) δ 9.36 (1H, br s, ArH), 8.40 (1H, dd, J = 8.5, 2.6 Hz, ArH), 7.84 
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ArH), 7.26 (1H, d, J = 8.5 Hz, ArH), 7.08 (2H, t, J = 7.2 Hz, ArH), 6.80 (2H, d, J = 
7.1 Hz, ArH), 5.02 (1H, t, J = 9.2 Hz, CHN), 3.73-3.62 (1H, m, CHCH2Ph), 3.03 
(1H, t, J = 12.3 Hz, CH2Ph), 2.54 (1H, dd, J = 13.5, 2.9 Hz, CH2Ph), 1.19 (9H, s, 
C(CH3)3); 
13
C NMR (125.8 MHz, (CD3)2SO)  167.3 (C), 154.4 (C), 147.6 (C), 
144.1 (CH), 142.8 (C), 138.7 (C), 132.4 (2 x CH), 131.0 (CH), 128.4 (2 x CH), 128.3 
(2 x CH), 128.1 (2 x CH), 126.0 (CH), 125.6 (CH), 118.8 (C), 110.1 (C), 78.2 (C), 
58.1 (CH), 53.6 (CH), 37.6 (CH2), 27.9 (3 x CH3); HRMS (ESI +ve) Exact mass 
calculated for C26H27N4O4 [M+H]
+
: 459.2027, found: 459.2027. Enantiomeric excess 
was determined by HPLC with a Chiralpak IA-3 column (80:20 hexane:i-PrOH, 1.0 
mL/min, 230 nm, 25 °C); tr (major) = 6.2 min, tr (minor) ca. 17.5 min (not observed), 
>99% ee.  
 
tert-Butyl N-[(1R,2S)-1-(3-methoxyphenyl)-2-(5-
nitropyridin-2-yl)-3-phenylpropyl]carbamate (1.108j).  
The title compound was prepared according to a slight 
modification of General Procedure A (in that the reaction temperature was 50 °C) 
from alkylazaarene 1.91b (114 mg, 0.50 mmol) and N-Boc imine 1.83i (176 mg, 0.75 
mmol) and purified by column chromatography (2→12% acetone/hexane) to give a 
93:7 inseparable mixture of diastereomers as a white solid (219 mg, 94%). Rf 0.16 
(20% acetone/hexane); m.p. 128-130 °C; [α]
20
D +1.6 (c 4.87, CH2Cl2);
 
 IR (film) 2978, 





H NMR (500 MHz, CD3OD) δ 9.38 (1H, br s, ArH), 8.23 (1H, 
dd, J = 8.5, 2.7 Hz, ArH), 7.23 (1H, t, J = 7.8 Hz, ArH), 7.16-7.00 (4H, m, ArH), 
6.97-6.80 (5H, m, ArH), 5.02 (1H, d, J = 8.1 Hz, CHN), 3.77 (3H, s, OCH3), 3.66-
3.31 (1H, m, CHCH2Ph), 3.06 (1H, dd, J = 13.3, 10.6 Hz, CH2Ph) 2.86 (1H, dd, J = 
13.5, 4.5 Hz, CH2Ph), 1.31 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CD3OD)  
169.4 (C), 161.4 (C), 157.2, (C), 145.4 (CH), 144.6 (C), 144.4 (C), 140.4 (C), 132.0 
(CH), 130.6 (CH), 129.9 (2 x CH), 129.3 (2 x CH), 127.2 (CH), 126.8 (CH) 120.3 
(CH), 113.8 (CH), 113.7 (CH), 80.3 (C), 59.5 (CH), 56.4 (CH), 55.7 (CH3), 39.9 
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Minor diastereomer (diagnostic peaks): 
1
H NMR (500 MHz, CD3OD) δ 9.24 (1H, d, 
J = 2.3 Hz, ArH), 8.04 (1H, dd, J = 8.5, 2.5 Hz, ArH), 6.79-6.69 (2H, m, ArH), 6.62 
(1H, ddd, J = 8.2, 2.5, 0.5 Hz, ArH), 5.09 (1H, d, J = 10.0 Hz, CHN), 3.39 (1H, dd, J 
= 13.4, 2.9 Hz, CH2Ph), 3.18 (1H, dd, J = 13.4, 11.5 Hz, CH2Ph), 1.46 (9H, 
C(CH3)3). HRMS (ESI +ve) Exact mass calculated for C26H30N3O5 [M+H]
+
: 
464.2180, found: 464.2179. Enantiomeric excess was determined by HPLC with a 
Chiralpak IA-3 column (90:10 hexane:i-PrOH, 2.0 mL/min, 230 nm, 25 °C); tr 
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Pd(II)-Catalysed Addition Reactions to Nitroalkenes 
General Procedure B 
To a mixture of the appropriate alkylazaarene (0.50 mmol) and the appropriate 
nitroalkene (0.75 mmol) at room temperature was added a solution of Pd(OAc)2 (5.5 
mg, 25 mol) and ligand L1.31 (12.2 mg, 25.1 mol) in CHCl3 (0.5 mL, alcohol-
free, amylene-stabilised). The reaction mixture was stirred at 50 °C for 24 h, filtered 
through a short plug of silica gel using 30% acetone/hexane as eluent, and 
concentrated in vacuo. Purification of the residue by column chromatography gave 
the addition product. 
 
6-Nitro-2-[(2R,3S)-1-nitro-2-phenylhexan-3-yl]-1,3-
benzoxazole (1.109a).  
The title compound was prepared according to General 
Procedure B from alkylazaarene 1.83d (110 mg, 0.50 mmol) and nitroalkene 1.65a 
(112 mg, 0.75 mmol) and purified by column chromatography (2→12% 
acetone/hexane) to give a yellow oil (107 mg, 58%). Rf 0.33 (20% acetone/hexane); 
[α]
20
D  +8.0 (c 0.98, CHCl3); IR (film) 3107, 2963, 1557, 1527 (NO2), 1456,  1344 




H NMR (500 MHz, CDCl3) δ 8.45 (1H, d, J = 2.0 
Hz, ArH), 8.33 (1H, dd, J = 8.8, 2.1 Hz, ArH), 7.83 (1H, d, J = 8.7 Hz, ArH), 7.40-
7.30 (3H, m, ArH), 7.25-7.21 (2H, m, ArH), 4.77 (1H, dd, J = 12.9, 10.0 Hz, CH2N), 
4.58 (1H, dd, J = 12.9, 4.8 Hz, CH2N), 4.02 (1H, app td, J = 9.9, 4.9 Hz, CHPh), 
3.48  (1H, app td, J = 10.3, 3.9 Hz, CHCH2CH2CH3), 1.88-1.75 (1H, m, 
CH2CH2CH3), 1.62-1.51 (1H, m, CH2CH2CH3), 1.22-1.11 (2H, m, CH2CH3), 0.78 
(3H, t, J = 7.3 Hz, CH3); 
13
C NMR (125.8 MHz, CDCl3)  171.8 (C), 149.7 (C), 
146.0 (C), 145.4 (C), 137.0 (C), 129.3 (2 x CH), 128.5 (CH), 127.8 (2 x CH), 120.8 
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(CH2), 13.6 (CH3); HRMS (ESI +ve) Exact mass calculated for C19H19N3O5 [M+H]
+
: 
369.1319, found: 369.1316. Enantiomeric excess was determined by HPLC with a 
Chiralpak IA-3 column (95:5 hexane:EtOH, 2.0 mL/min, 254 nm, 25 °C); tr (major) 
= 13.0 min, tr (minor) = 14.2 min, 90% ee. 
5-Nitro-2-[(2R,3S)-4-nitro-1,3-diphenylbutan-2-yl]pyridine 
(1.109b).  
The title compound was prepared according to General 
Procedure B from alkylazaarene 1.91b (114 mg, 0.50 mmol) and nitroalkene 1.65a 
(112 mg, 0.75 mmol) and purified by column chromatography (2→12% 
acetone/hexane) to give a pale yellow solid (138 mg, 73%). Slow diffusion of hexane 
into a solution of 1.109b in chlorobenzene gave crystals that were suitable for X-ray 
diffraction. Rf 0.14 (20% acetone/hexane); m.p. 126-128 ºC; [α]
20
D –51 (c 1.03, 





H NMR (500 MHz, CDCl3) δ 9.49 (1H, d, J = 2.5 Hz, ArH), 8.20 
(1H, dd, J = 8.5, 2.7 Hz, ArH), 7.44-7.39 (2H, m, ArH), 7.38-7.29 (3H, m, ArH), 
7.13-7.05 (3H, m, ArH), 6.86 (1H, dd, J = 8.4, 0.3 Hz, ArH), 6.75-6.67 (2H, m, 
ArH), 4.58 (1H, dd, J = 12.6, 9.8 Hz, CH2N), 4.04 (1H, dd, J = 12.6, 4.5 Hz, CH2N), 
4.17 (1H, td, J = 9.9, 4.4 Hz, CHCH2N), 3.53 (1H, td, J = 9.8, 5.3 Hz, CHCH2Ph), 
2.94-2.84 (2H, m, CH2Ph); 
13
C NMR (125.8 MHz, CDCl3)  167.3 (C), 145.3 (CH), 
142.9 (C), 138.4 (C), 137.8 (C), 131.0 (CH), 129.3 (2 x CH), 128.5 (2 x CH), 128.4 
(2 x CH), 128.3 (CH), 128.0 (2 x CH), 126.4 (CH), 124.9 (CH), 78.6 (CH2), 53.4 
(CH), 48.2 (CH), 40.2 (CH2); HRMS (ESI +ve) Exact mass calculated for 
C21H19N3O4 [M+H]
+
: 377.1370, found: 377.1372. Enantiomeric excess was 
determined by HPLC with a Chiralpak IA-3 column (70:30 hexane:EtOH, 1.0 
mL/min, 210 nm, 25 °C); tr (major) = 9.0 min, tr (minor), ca. 9.5 min, >99% ee. 
5-Nitro-2-[(2S,3S)-4-nitro-1-phenyl-3-(thiophen-2-
yl)butan-2-yl]pyridine (1.109c).  
The title compound was prepared according to a slight 
modification of General Procedure B (in that the reaction 
temperature was 60 °C and the reaction time was 48 h) from alkylazaarene 1.91b 
(114 mg, 0.50 mmol) and nitroalkene 1.65c
[66]
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column chromatography (2→16% acetone/hexane) to give a brown gum (138 mg, 
78%). Rf 0.20 (20% acetone/hexane); [α]
20
D  –55 (c 1.00, CHCl3); IR (film) 1601, 




H NMR (500 
MHz, CDCl3) δ 9.49 (1H, d, J = 2.6 Hz, ArH), 8.19 (1H, dd, J = 8.5, 2.7 Hz, ArH), 
7.32 (1H, t, J = 3.2 Hz, ArH), 7.15-7.10 (3H, m, ArH), 7.01 (2H, d, J = 3.5 Hz, 
ArH), 6.85 (1H, dd, J = 8.5, 0.6 Hz, ArH), 6.79-6.75 (2H, m, ArH), 4.56-4.43 (3H, 
m, CH2NO2, CHCH2N), 3.55-3.50  (1H, m, CHCH2Ph), 3.07 (1H, dd, J = 13.4, 3.9 
Hz, CH2Ph), 2.92 (1H, dd, J = 13.4, 11.0 Hz, CH2Ph); 
13
C NMR (125.8 MHz, 
CDCl3)  166.8 (C), 145.3 (CH), 143.0 (C), 140.7 (C), 138.2 (C), 131.0 (CH), 128.6 
(2 x CH), 128.4 (2 x CH), 127.3 (CH), 127.0 (CH), 126.6 (CH), 125.4 (CH), 125.1 
(CH), 79.2 (CH2), 54.4 (CH), 43.6 (CH), 40.3 (CH2); HRMS (ESI +ve) Exact mass 
calculated for C21H24N3O5 [M+H]
+
: 383.0934, found: 383.0933. Enantiomeric excess 
was determined by HPLC with a Chiralpak IA-3 column (80:20 hexane:i-PrOH, 2.0 
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2. SYNTHESIS OF SPIROCYCLIC ENONES VIA RH(III)-
CATALYSED C–H FUNCTIONALISATION  
2.1 INTRODUCTION  
Transition metal-catalysed C–H functionalisation reactions have attracted much 
attention among many research groups over the last couple of decades, as they 
provide shorter synthetic routes for delivering complex molecules. Moreover, this 









 reactions, enables formation of new C–
C, C–X  bonds (X = heteroatom) without preactivating substrates. From an atom- 
and step-economical point of view this is highly desirable. Furthermore, generation 
of toxic by-product waste is reduced, thus making this process more environmentally 
friendly. 
To understand the functionalisation of the “inert” C–H bond, mechanistic studies 
have been conducted and showed that depending on the metal character, four types 
of metallation mechanisms can be distinguished: oxidative addition, σ-bond 
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The based-assisted metallation mechanism has been widely studied in the oxidative 
heteroatom-directed functionalisation of aromatic C–H bonds in the reactions with 







catalysts will be presented in this part of the thesis as they stand out for functional 
group tolerance. The oxidative heteroatom-directed approach itself is one of the most 
promising areas of C–H functionalisation chemistry, where the metal centre of the 
catalyst coordinates to the built-in directing group of the substrate to functionalise a 
C(sp
2
)–H bond and form metalacycle 2.1 (Scheme 2.2).
[9]
 Subsequent coordination 
and migratory insertion of the alkyne (or 1,3-enyne) followed by C–X (X = 
heteroatom) reductive elimination delivers hetero- or carbocyclic product 2.2. 
Furthermore, as the C–H bond acts as a poor Lewis base, the introduction of a 
substituent on the reagent, can alter its character and thus, make this process site-
selective.
[10]
 The directing groups used in these reactions are commonly known 
functional groups such as carboxylic acids, naphthols and imines.  
 
Scheme 2.2: Existing alkyne oxidative annulations by X-H/C(sp
2
)-H bond cleavage 
Due to the high interest within our group, in regards to oxidative heteroatom-directed 
C(sp
2
)–H functionalisation reactions with alkynes, attempts have been made to 
broaden the substrate scope in this area. Thus, the recent work on the use of 2-
alkenylphenols in the oxidative annulation reactions with alkynes and 1,3-enynes to 
form spirocyclic enones will be described here. However, a brief overview, of N- and 
O-containing directing groups, based on existing literature, will be presented first. 
2.2 NITROGEN-CONTAINING DIRECTING GROUPS  
This section highlights some examples of various N-containing directing groups 
which have been widely studied in transition-metal catalysed alkyne oxidative 
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positioned at the nitrogen atom that coordinates to the metal centre and promotes a 
substrate-catalyst interaction leading to site-selective C–H bond cleavage. 
Subsequent alkyne migratory insertion, followed by reductive elimination, gives the 
annulated product. 
2.2.1 AMIDES 
The first Rh-catalysed oxidative annulation reaction of alkynes 2.4 with acetanilides 
2.3 to deliver N-acetyl indoles 2.5 was reported by Fagnou in 2008.
[11]
 The optimal 
conditions were found to be 2.5 mol% [Cp*RhCl2]2 catalyst, 2.0 equivalents 
Cu(OAc)2·H2O, 10 mol% AgSbF6 in t-AmOH at 120 °C (Scheme 2.3). The products 
were obtained in moderate to high yields and the reaction was also tolerant towards 
alkyl/aryl alkynes. 
 
Scheme 2.3: Indole synthesis via Rh-catalysed annulation of alkynes with acetanilides.
[11]
  
This methodology was later modified by the introduction of 
[Cp*Rh(MeCN)3][SbF6]2 complex and air as a co-oxidant to remove the need for the 
addition of a silver salt and to reduce the super-stoichiometric amount of 
Cu(OAc)2·H2O oxidant. These reaction conditions were then applied to the synthesis 
of pyrroles.
[12]
 Later that year, the same group showed that the synthesis of various 
unsymmetrical 2,3-aliphatic-substituted indoles and pyrroles can be achieved in the 
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2.2.2 PROTECTED ANILINES 
In 2012, Ackermann and co-workers reported the Ru-catalysed reaction of 2-
pyrimidine protected anilines 2.6 with alkynes 2.4 which resulted in the formation of 
various substituted indole products 2.7 (Scheme 2.4).
[14]
 The active cationic Ru(II) 
complex, with weakly coordinating anion PF6
ˉ
, was generated from [RuCl2(p-
cymene)]2  and KPF6. The efficiency of the reaction was high and delivered a broad 
range of the indole products 2.7. Diaryl, dialkyl and unsymmetrical alkenes were 
well tolerated. Moreover, the reaction was conducted in water as a sustainable 
solvent.  
 
Scheme 2.4: Ru-catalysed oxidative annulation of protected anilines with alkynes.
[14]
  
An alternative approach for the synthesis of N-substituted indoles was presented by 
the group of Huang.
[15]
 They envisioned that introduction of a functional group that 
would serve as a directing group and in-built oxidant, would make this reaction 
redox-neutral. Further investigation revealed that under Ru(II) catalysis pyrazolidin-
2-ones 2.8 were good substrates for the oxidative annulation with alkynes 2.4 and 









Scheme 2.5: Ru-catalysed oxidative annulation of pyrazolidin-2-ones with alkynes.
[15]
 
The proposed mechanism of this reaction is slightly different from the general one, 
previously described for the Ru-catalysed oxidative annulation processes. After 
acetate-assisted cyclometallation and alkyne insertion to give intermediate 2.10, the 
Ru(II) complex is further oxidised to Ru(IV) 2.11 by N–N bond cleavage. The 
release of the final product 2.9 occurs after reductive elimination (Scheme 2.6). 
 
Scheme 2.6: Proposed mechanism of the indole synthesis via N–N bond cleavage.
[16]
 
Based on pioneering work by Fagnou in 2008,
[11]
 regarding Rh-catalysed indole 
synthesis using acetanilides, the Rovis group proposed using amides 2.12 as a 
directing group for delivering isoquinolones 2.13 via C–H bond cleavage and 
subsequent C–N bond formation (Scheme 2.7).
[17]
 In general, this reaction worked 
smoothly in the presence of [Cp*RhCl2]2 (2.5 mol%) and a super-stoichiometric 
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aryl and alkyl alkynes as well as unsymmetrical variants, gave the final 
isoquinolones 2.13 in moderate to high yields. This process also tolerated various 
substituents at the nitrogen atom and aryl ring of the amide (2.13a and 2.13b). A year 
later a less expensive [RuCl2(p-cymene)]2 catalyst for the oxidative annulation of 
alkynes with amides was investigated and published by Ackermann and co-
workers.
[18]
 The efficacy of this process was as good as the Rh-catalysed reaction.  
 
Scheme 2.7: Synthesis of isoquinolones via Rh-catalysed oxidative annulation of alkynes.
[17]
 
The mechanism proposed by Rovis is shown below (Scheme 2.8). The success of this 
reaction is due to the heteroatom assistance, in this case the nitrogen atom of the 
amide group. Coordination of the amide to the active catalyst [Cp*Rh(OAc)2] 2.14 
facilitates site-selective C(sp
2
)–H functionalisation to form rhodacycle 2.15. This 
carbometallation proceeds with a carboxylate assistance allowing then migratory 
insertion of an alkyne to form the 7-membered rhodacycle 2.16. Reductive 
elimination releases the final product 2.13 and Rh(I) catalyst which is oxidised with 








Scheme 2.8: Rh-catalysed oxidative annulation of alkynes to form isoquinolones.
[17]
 
Further exploration of substrate scope by Ackermann and co-workers showed that 
the reaction of various acrylamides 2.17 with alkynes 2.4 under ruthenium catalysis, 
with a Cu(OAc)2·H2O oxidant in t-AmOH at 120 °C can provide a range of 2-
pyridones 2.18 (Scheme 2.9).
[19]
 In comparison with the Rh-catalyst, previously 
described by Li,
[20]
 this ruthenium catalysed reaction did not require super-
stoichiometric amounts of the external oxidant and was efficient for dialkyl 
substituted alkynes (which afforded a complicated mixture of compounds in the 
corresponding Rh-catalysed process). The addition of alkyl/aryl-substituted alkynes 
was site-selective regardless of the nature of the substituent at the N-amide position 








Scheme 2.9: Synthesis of 2-pyridones under Ru-catalysis.
[19]
 
2.2.3 BENZHYDROXAMIC ACIDS 
In 2010, Fagnou and co-workers reported an intermolecular process that delivered 
the isoquinolone products 2.20 via Rh-catalysed annulation of benzhydroxamic acids 
2.19 with alkynes 2.4 (Scheme 2.10).
[21]
 The reaction worked smoothly without the 
addition of an external oxidant. The active catalyst was regenerated via N–O bond 
cleavage present in the substrate as a built-in oxidant. In general, electron-
withdrawing and donating groups on the aryl ring were well tolerated as well as 
symmetrical aryl or unsymmetrical alkyl/aryl alkynes. The reaction did not work for 








Scheme 2.10: Rh-catalysed oxidative annulation of isoquinolones.
[21]
 
Following these observations, an alternative method for the synthesis of 
isoquinolones 2.20 via C–H activation using an oxidising methoxy group was 




 Wang`s conditions 
required running the reaction of benzhydroxamic acids 2.19 with alkynes 2.4 with 3 
mol% [RuCl2(p-cymene)]2 catalyst and 20 mol% NaOAc in methanol at room 
temperature. The addition of NaOAc was required as the acetate anion takes part in 
the cyclometallation step and regenerates the catalyst. Notably, Ackermann showed 
that a catalytic system consisting of 2.5 mol% [RuCl2(p-cymene)]2, 30 mol% of 
KO2CMes as a carboxylate source,  in water was also highly effective (Scheme 
2.11). 
 










Satoh and Miura had also shown that N-benzylideneanilines 2.21 can react with 
internal alkynes 2.4 using 2 mol% [Cp*RhCl2]2 and 2.0 equivalents Cu(OAc)2·H2O 
in DMF at 80 °C under N2 to give indenone imines 2.22 (Scheme 2.12).
[24]
 With 
respect to substrate scope various N-benzylideneanilines were tolerated regardless of 
the electronic character of the substituent. However, an N-alkylimine, e.g. 
benzylidene N-tert-butylamine, was recovered under optimised reaction conditions. 
Symmetrical diaryl alkynes gave good to high yields (compounds 2.22a and 2.22b), 
whereas the reaction with dialkyl, 4-octyne yielded the indenone product 2.22c in 
only 32%. The terminal alkynes phenylacetylene underwent dimerisation forming 
diphenylbutadiyne instead. 
 
Scheme 2.12: Rh-catalysed indenone imine formation.
[24]
 
A plausible mechanism in the reaction of N-benzylideneaniline with alkynes is 
highlighted in Scheme 2.13. Formation of the active catalyst 2.14 via ligand 
exchange with Cu(OAc)2·H2O occurs first. Coordination of the catalyst to the 
nitrogen atom of the imine facilitates the acetate-assisted C–H bond cleavage to form 
a five-membered rhodacycle 2.23. Coordination and migratory insertion of the 
alkyne 2.4 forms the seven-membered ring intermediate 2.24 which undergoes 
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forms the indenone imine final product 2.22 and the Rh(I) catalyst is reoxidised to 
Rh(III). 
 
Scheme 2.13: A plausible mechanism for the indenone imine formation.
[24]
 
Furthermore, under similar conditions benzophenone imine 2.26 reacted with internal 
alkynes 2.4 to give isoquinoline product 2.27 (Scheme 2.14). Dialkyl, diaryl as well 
as the unsymmetrical alkynes were well tolerated in this reaction giving high yields 
of the final product. 
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Simultaneously, Guimode and Fagnou showed that isoquinolines 2.27 can be 
obtained in the reaction of N-tert-butylbenzaldimine 2.28 with internal alkynes 2.4 in 
the presence of 2.5 mol% [Cp*Rh(MeCN)3][SbF6]2, 2.1 equivalents Cu(OAc)2·H2O 
in DCE at reflux (Scheme 2.15).
[25]
 This reaction worked well for dialkyl alkynes; 
however there are no examples for diaryl alkynes. Unsymmetrical alkynes gave the 
final product with up to >19:1 regioselectivity. Terminal alkynes were not good 
coupling partners, giving the alkyne dimerised product instead. 
 
Scheme 2.15: Rh-catalysed isoquinoline 2.27 formation.
[25]
  
2.3 O-BASED DIRECTING GROUPS 
In the previous section it was shown that various N-containing hetero- and 
carbocycles could be easily prepared by the use of N-coordinating directing groups in 
the oxidative coupling reactions with alkynes. Catalytic, direct C–H functionalisation 
of substrates containing O-based directing groups has also received a lot of attention 
in the last decade due to the formation of biologically significant molecules. Below, 
commonly used functional groups in this oxidative annulation process are described. 
2.3.1 CARBOXYLIC ACIDS  
One of the pioneering studies, describing an alkyne oxidative annulation process, 
was reported by the group of Satoh and Miura in 2007.
[26],[27]
 They showed that the 
employment of benzoic acids 2.29 and internal alkynes 2.4 can provide a wide range 









 Various Rh-based catalysts such as RhCl3·H2O, Rh(acac), 
[RhCl(cod)2]2 or [RhCl(C2H2)]2 (acac = acetylacetonate, cod = 1,5-cyclooctadiene) 
were not efficient for this transformation. However, the optimised reaction 
conditions consisted of 0.5 mol% [Cp*RhCl2]2 catalyst and 2.0 equivalents of 
Cu(OAc)2·H2O oxidant in o-xylene at 120 °C and provided the final products with 
satisfying yields and high regioselectivity (Scheme 2.16). This procedure worked 
smoothly for various internal alkynes but was not effective for terminal or silyl-
protected alkynes. Furthermore, running the reaction with a catalytic amount of 
oxidant under an air atmosphere was also efficient in delivering isocoumarins. 
 
Scheme 2.16: Formation of isocoumarins under Rh-catalysis.
[26],[27] 
During the reaction, the carboxylate oxygen chelates to the metal centre and 
facilitates the site-selective C(sp
2
)–H bond cleavage, via acetate assistance, to form a 
five-membered rhodacycle 2.31 (Scheme 2.17). Then, a migratory alkyne insertion 
generates a seven-membered rhodacycle 2.32 which undergoes reductive elimination 
to form the isocoumarin product 2.30. Oxidation of the catalyst with Cu(OAc)2·H2O 









Scheme 2.17: Proposed mechanism for isocoumarin formation.
[26],[27] 
Despite the versatility of both methods, the cost of the catalyst and low abundance of 





 published independently an alternative 
synthesis of isocoumarins 2.30 via the cationic Ru(II)-catalysed oxidative annulation 
of aromatic acids 2.29 and alkynes 2.4 (Scheme 2.18). Furthermore, they both 
showed that the reaction proceeds smoothly with symmetrical dialkyl/diaryl alkynes 
and was highly regioselective for alkyl/aryl alkynes. The substrate scope with 
regards to aryl carboxylic acids and their derivatives was also investigated. Both 
groups used different silver salts for the formation of the active cationic Ru(II) 
complex. In Ackermann`s studies AgPF6 was used, while Jeganmohan`s conditions 
required the addition of AgSbF6. The latter counterion played an important role in 










Scheme 2.18: Ru-catalysed oxidative annulation of aryl carboxylic acids with alkynes.
[29],[30]
  
2.3.1.1 Phosphinic acids and phosphonic monoesters 
Attention has also been given to phosphinic aids and their monoesters, which have 
been used to form biologically active phosphaisocoumarines.
[31]
 For example, in 
2013 the group of Satoh and Miura,
[32]
 as well as the Lee group
[33]
 reported 
independently, the Rh-catalysed oxidative annulation of alkynes directed by 
phosphonic acids and their monoesters. Subsequently, a Ru-catalysed alternative 
process for the formation of these phosphorus heterocyclic compounds 2.34 was also 
developed by the Lee group (Scheme 2.19).
[34]
 This reaction worked using a Ru(II)-
catalyst (10 mol%) with a combination of two oxidising agents, AgCO3 and AgOAc 
(1 equivalent of each). Aryl phosphonic acids and their monoester derivatives 
possessing electron-donating or withdrawing groups were cyclised with a range of 
diaryl, dialkyl and aryl/alkyl alkynes giving high yields (2.34a–c). The mechanism is 
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hydroxyl chelation to the Ru metal centre which allows the C–H 
activation/functionalisation. C–O bond formation via reductive elimination releases 
the phosphaisocoumarin product. 
 
Scheme 2.19: Ru-catalysed synthesis of phosphaisocoumarins by the Lee group.
[34]
 
2.3.2 BENZYLIC ALCOHOLS 
The group of Satoh and Miura investigated a Rh-catalysed oxidative annulation 
reaction of α,α-disubstituted benzylic alcohols 2.35 with alkynes 2.4.
[35]
 In 2011, 
they showed that the catalytic system of 4 mol% [Cp*Rh(MeCN)3][SbF6]2, 2 
equivalents Cu(OAc)2·H2O in 1,4-dioxane at reflux was effective for the synthesis of 
isochromenes 2.36 (Scheme 2.20). 
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Following the development of this methodology, the group of Ackermann presented 
their work on the Ru-catalysed oxidative annulation of α,α-dialkyl substituted 
benzylic alcohols 2.37 with alkynes 2.4 (Scheme 2.21).
[36]
 During the optimisation of 
the reaction conditions, it was found that the loading of the external oxidant, 
Cu(OAc)2·H2O, could be lowered to 0.5 equivalent in the presence of air as a co-
oxidant. Overall, diaryl and dialkyl alkynes were tolerated (compounds 2.36d and 
2.36e), with moderate regioselectivity for unsymmetrical alkynes with the major 
product possessing the aryl group proximal to oxygen substituent (2.36f). 
Unfortunately, terminal alkynes were not successful coupling partners for this 
transformation. 
 




The utility of commercially available phenols and their derivatives in transition-
metal catalysed oxidative annulation reactions of alkynes has been of high interests. 
The group of Sahoo and co-workers demonstrated the synthesis of 2,3-disubstituted 
benzofurans 2.39 in the reaction of phenols 2.38 with alkynes 2.4.
[37]
 The highest 
yields were obtained using the combination of [Pd2(dba)3] catalyst, 1,10-
phenanthroline ligand, Cu(OAc)2·H2O and NaOAc (Scheme 2.22). Simultaneously, 
the group of Shi also achieved the direct synthesis of benzofurans ;
[38]
 however, the 
Rh(III)/Cu(II)-catalysed process was not efficient for dialkyl or alkylaryl alkynes in 
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these sets of results are significant because they prove the ability of phenols to form 
homocoupled products in the presence of oxidants.
[39],[40]  
 




1-Naphthols and their analogues have been used in oxidative annulation reactions 
with alkynes and was reported in 2010 by Satoh and Miura.
[41]
 In their elegant work 
they showed that with [Cp*RhCl2]2 catalyst and Cu(OAc)2·H2O oxidant, the C–H 
bond cleavage occurred at the peri position of the 1-naphthol to give the fused 
polycyclic product. This method proved to be successful only for symmetrical 
alkynes. 
An alternative approached for the synthesis of naphthalpyrans 2.41 was presented by 
Ackermann and co-workers in 2012.
[42]
 In the presence of 2.0 mol% [RuCl2(p-
cymene)]2 catalyst, 2.0 equivalents Cu(OAc)2·H2O, various 1-naphthols 2.40 and 
alkynes 2.4 delivered ample scope of naphthalpyrans 2.41 (Scheme 2.23). This 









Scheme 2.23: Ru-catalysed oxidative annulation of 1-naphthols 2.40 and alkynes 2.4.
[42]
 
This catalytic system was also tested in the reaction of various alkynes 2.4 with 4-
hydroxycoumarin 2.42 and quinoline-2-one 2.43 giving the final products 2.43 or 
2.44 in high yields. (Scheme 2.24). This process delivered a novel range of 
fluorescent pyrans via high regio-, site- and chemo-selective C–H/C–O bond 
functionalisation.  
 
Scheme 2.24: Ru-catalysed synthesis of fluorescent pyrans.
[42]
 
Recently, the group of Luan and co-workers reported the formation of spirocyclic 
products 2.46 via a C–H activation-dearomatisation tandem process of 1-
(hetero)aryl-2-naphthols 2.45 with alkynes 2.4.
[43]
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found to be a catalyst system consisting of 2.5 mol% [(RuCl2(p-cymene)]2, 2.1 
equivalents Cu(OAc)2·H2O, and 2.0 equivalents of K2CO3 in 1,4-dioxane at 90 °C for 
48 h (Scheme 2.25). In terms of substrate scope, the aryl and naphthol rings could be 
substituted at various positions and gave the annulated final products in high yields 
(products 2.46a and 2.46b). Changing the substituent from aryl to a heteroaryl 
system at the 1-position of the naphthol was also successful (81%, compound 2.46c). 
Overall, the final products were obtained as single regioisomers or >19:1 mixtures 
when unsymmetrical alkynes were employed (2.46a–d). Symmetrical alkynes, such 
as diphenylacetylene, were tolerated (2.46f); however in the intermolecular 
competition experiment, it was noticed that electron-rich alkynes delivered the final 
product in better yield. 
 
Scheme 2.25: Ru-catalysed spiroannulation of (hetero)aryl naphthols.
[43]
 
This Ru-catalysed system was efficient for 1-aryl-2-naphthols; however the 
optimised conditions, as well as other screened Rh- and Pd-based catalysts, were not 
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of dearomatisation of the phenol substrate is more challenging in comparison with 2-
naphhtols. (Studies utilising phenols and their derivatives in oxidative annulation 
directed C–H functionalisation reactions with alkynes can be found in the Research 
and Discussion Part). 
Luan and co-workers also showed that 2-naphhtols 2.47 and 2.5 equivalents of 
alkynes 2.4 in the presence of Pd(OAc)2 catalyst and Cu(OAc)2·H2O oxidant can 
form a range of spirocyclic compounds via [2 + 2 + 1] oxidative annulation(Scheme 
2.26).
[44]
 Other transition-metal catalysts, commonly used in C–H functionalisation 
reactions, based on Rh, Rh or Pd, were not effective for this transformation. Overall, 
various substituents introduced at the 2-naphthol ring were tolerated regardless of 
their electronic character. Dialkyl, di(hetero)aryl and unsymmetrical alkynes 
underwent spiroannulation giving good to high yields and in high regioselectivity.  
 
Scheme 2.26: Pd-catalysed one-pot synthesis of spiroannulated 2-naphthols.
[44]
 
A mechanism of this double alkyne addition was also proposed (Scheme 2.27). 
Deprotonation of 2-naphthol substrate 2.47 by Pd(OAc)2 forms the 
palladiumphenoxide species 2.49a which tautomerises to give palladium enolate 
2.49b. Coordination and migratory insertion of the alkyne creates a six-membered 
palladacycle 2.50 which rearomatises under base assistance to give 2.51. A 
subsequent migratory insertion of a second alkyne molecule affords a strained eight-
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Finally, reductive elimination delivers the spirocyclic product 2.48 and Pd(0) which 
undergoes subsequent re-oxidation to finish the catalytic cycle. 
 
Scheme 2.27: Synthesis of spirocycles via Pd-catalysed double alkyne additions to  




During the course of our studies regarding phenols as potential starting materials for 
C–H functionalisation processes (See the Research and Discussion Part), the group 
of Gulias and Mascareñas published similar results to those obtained in our 
laboratory. They investigated a [5+2] cycloaddition reaction between o-vinylphenols 
2.54 and alkynes 2.4 under Rh catalysis (Scheme 2.28).
[45]
 This resulted in the 
formation of benzoxepine products 2.55 and proceeds via C–H activation of the vinyl 
C(sp
2
)–H bond followed by an annulation process. The reaction was tolerated for 
symmetrical diaryl-substituted alkynes (2.55a, 2.55d, 2.55e), dialkyl alkynes (2.55b), 
and for unsymmetrical alkynes (2.55c and 2.55f). With the latter, the regioselectivity 
was high and ranged from 14:1 to ≥ 20:1, in which the aryl group was attached to the 
carbon tethered to the oxygen group in the major product. Introduction of 








Scheme 2.28: Rh-catalysed formation of benzoxepine 2.55 from o-vinylphenols 2.54.
[45]
 
The utility of this method was also applied to the synthesis of coumarins 2.57, by the 
replacement of alkynes with carbon monoxide 2.56 (Scheme 2.28). 
 
Scheme 2.29: Rh-catalysed synthesis of coumarins 2.57.
[45]
 
Simultaneously, investigations carried out by our group
[46]
 and that of Gulias and 
Mascareñas,
[47]
 showed that 2-alkenyl phenols possessing a substituent at the internal 
position of the alkene, under Rh catalysis, provided the spiroenone product 2.80 








As discussed so far there are a wide range of ortho-directing groups such as 
carboxylic or phosphonic acids and their monoesters or benzylic alcohols which are 
useful for forming new C–C or C–X bonds (X = heteroatom) and thus enable 
alternative approaches in building a wide range of important heterocycles or 
carbocycles. To further broaden the library of compounds for transition-metal 
catalysed oxidative annulation processes, the Lam group became interested in 2-aryl-
1,3-dicarbonyls. Due to the high acidity of these compounds, they exist mainly in the 
enol tautomeric form. This enolic intermediate possesses a hydroxyl group, similar to 
that presented by carboxylic acids. It was proposed that this functional group could 
act as a directing group for C(sp
2
)–H bond cleavage and react with an alkyne to form 
the oxidative annulated product. However, in screening this reaction the carbocyclic 
product 2.59 was only observed with no traces of the expected O-containing 
heterocyclic compound 2.60 (Scheme 2.30). 
 
Scheme 2.30: Formation of spiroindene compounds via C(sp
2
)–H cleavage. 
Pleasingly, performing the reaction of 2-aryl cyclic 1,3-dicarbonyl compounds 2.58 
with alkynes 2.4 in the presence of [(RuCl2(p-cymene)]2 catalyst, Cu(OAc)2 oxidant 
in 1,4-dioxane at 90 °C, a range of complex spirocyclic indenes 2.59 were achieved 
(Scheme 2.31).
[48]
 Comparable results were obtained with [Cp
*
RhCl2]2 but due to the 
cost of the catalyst, the reaction was performed with Ru-catalyst instead. The 
substrate scope was not only limited to 1,3-dicyclohexanone based products 2.59a–c, 
but it was also shown that the barbituric 2.59d–e and Meldrum`s acid-derived 
starting materials 2.59f, underwent the annulation process successfully. However, the 
latter required an addition of K2CO3 base to push the equilibrium towards the enol 
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reactions proceed smoothly for symmetrical, unsymmetrical as well as for 
aryl/heteroaryl alkynes. 
 
Scheme 2.31: Ru-catalysed oxidative additions of various 1,3-dicarbonyls with alkynes.
[48]
  
The proposed mechanism for this reaction is shown in Scheme 2.32. Under the 
optimised reaction conditions, the formation of an enolate occurs first, followed by 
the coordination with complex 2.60 to form six-membered ruthenacycle 2.61. 
Coordination and migratory insertion of an alkyne 2.4, generates a second 
ruthenacycle, depicted as oxa-π-allylruthenacycle 2.62. Finally, reductive elimination 
of complex 2.62 gives the spiroindene product 2.59. The oxidation of Ru(0) back to 








Scheme 2.32: Proposed catalytic cycle for Ru-catalysed oxidative spiroannulation.
[48]
 
In the previously investigated cases, the symmetrical dicarbonyl substrates only 
contained one possible site of reactivity for the C(sp
2
)–H cleavage, thus could only 
lead to one spiroindene product in the coupling reaction with alkynes. At this point, 
the Lam group wondered whether C–H functionalisation strategy could be applied 
for unsymmetrical substrates possessing multiple reactive C–H bonds. It was hoped 
that site-selectivity could be controlled by a catalyst and lead to the formation of one 
preferentially. 
3-Aryl-4-hydroxyquinolin-2-one 2.63 was taken into this investigation as it possesses 
two reactive sites for enolate-directed C(sp
2
)–H  bond cleavage, one at the 3-aryl ring 
H
A
 and the second one at the benzene ring of the quinolin-2-one H
B
. If the 
hypothesis was right, then the site-selective and switchable C–H functionalisation 












Scheme 2.33: Site-selective C–H functionalisation of 3-aryl-quinolin-2-ones with alkynes.
[49]
 
After intensive studies, it was found that unsymmetrical 3-aryl cyclic 1,3-dicarbonyls 
2.63 did provide these two different products depending on the catalyst used in the 
reaction. In the presence of PdPEPPSI-IPr catalyst (2.5 mol%) and 2.1 equivalents of 
Cu(OAc)2 in DMF at 120 °C, the reaction favoured the formation of spirocyclic 
compounds 2.64 (Scheme 2.34). In general, alkyl/aryl alkyne as well as 
diphenylacetylene worked fine for this transformation, giving 2.64a and 2.64b in 
55% and 83% yield, respectively. Introduction of the methoxy substituent at the 3-
aryl group (2.64b) or methyl at the 1,3-dicarbonyl ring (2.64c) was tolerated. The 
reaction proceeded smoothly using the free NH substrate (compound 2.64d), 
however, changing for the lactone derivative was not effective and gave the final 








Scheme 2.34: Pd-catalysed spiroindenes formation.
[49]
 
An analogous experiment was conducted where unsymmetrical 3-aryl cyclic 1,3-
dicarbonyls 2.63 and alkynes 2.4 were catalysed by using 5 mol% [RuCl2(p-
cymene)]2 at 90 °C. This led to the formation of benzopyrans 2.65 as the major 
products, along with small quantities of spiroindenes 2.64 (Scheme 2.35). Similarly 
to the Pd-catalysed process, alkyl/aryl alkynes and diphenylacetylene were tolerated 
and gave the annulated products in high yields; however as a 13:1 mixture of 
regioisomers in case of product 2.65a. Furthermore, substituents on the 3-aryl ring 
and the 1,3-dicarbonyl are tolerated, compounds 2.65b and 2.65c. In complete 
contrast to the Pd results, the free N–H starting material 2.63d did not form any 
product, whereas the lactone substrate 2.63e, which was relatively unsuccessful at 









Scheme 2.35: Ru-catalysed benzopyran formation.
[49]
 
Building upon this work, the Lam group and have recently shown that electron-
deficient 1,3-dicarbonyls 2.66, in the presence of 2.5 mol% [Cp*RhCl2]2 catalyst, 2.1 
equivalents of Cu(OAc)2 and with the addition of 0.1 equivalent of AcOH in 1,4-
dioxane at 60 °C, undergo oxidative annulation with 1,3-enynes 2.67 to give 
benzopyrans 2.68 (Scheme 2.36).
[50]
 Their studies revealed that the product 
formation is dependent on the electronic character of the starting material. 
Introduction of strongly electron-withdrawing groups at the aryl ring of the 1,3-
dicarbonyls, such as nitro, led to the formation of benzopyran 2.68 as the only 
product. In contrast, 2-aryl-1,3-dicarbonyls possessing electron-neutral or electron-
donating substituents at the aryl ring yielded the spiroindene 2.69 as the major 
product with some quantities of benzopyran 2.68 as a by-product (Scheme 2.36). The 
formation of benzopyrans was then investigated further. Under the optimised 
reaction conditions, a range of 1,3-enynes were screened and revealed that 1,3-
enynes need hydrogen in the allylic position cis to the alkyne. Thus, 1,3-enynes 
containing a phenyl substituent trans to the alkyne, or a protected 2-hydroxylethyl 
worked well and gave the final benzopyrans 2.68a and 2.68b in 73% and 84% yields, 
respectively. This reaction was not limited to substrates containing a methylene 









Scheme 2.36: Formation of benzopyrans from 1-aryl-1,3-dicarbonyls and 1,3-enynes.
[50]
 
This methodology was also applied to substrates containing other directing group 
such as enols, phenols, carboxylic acids, or imides to form various heterocyclic 
products. Selected examples are shown in Scheme 2.37.  
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 previously reported studies regarding alkynes and 
1,3-enynes in oxidative annulation reactions (Scheme 2.38). First, formation of the 
active catalyst 2.14 occurs via ligand exchange with Cu(OAc)2. Next, C–H 
functionalisation of 3-aryl-1,3-dicarbonyl 2.66 forms rhodacycle 2.71. Coordination 
and migratory insertion of an enyne 2.67 leads to the oxy-π-allylrhodacycle 2.72. As 
described before in Scheme 2.36, formation of a spirocyclic enone 2.69 is favoured 
when the aryl ring of the starting material possesses electron neutral or electron-
donating group, making the substrate easier to oxidise via reductive elimination step. 
However, the intermediate 2.72 may also be protonated by an addition of AcOH to 
form species 2.73, which can then undergo 1,4-Rh(III) migration to give σ-
allylrhodium species 2.74A. Through isomerisation processes, formation of the π-
allylrhodium species 2.74B occurs, followed by the attack of the enolic oxygen to 
provide the benzopyran product 2.68 or 2.70. Oxidation of Rh(I) with Cu(OAc)2 
regenerates the active catalyst. The key step in this reaction is 1,4-Rh(III) migration 
enabling an the 1,3-enyne to function as a one-carbon coupling partner. This 
isomerisation process can only occur when 1,3-enyne coupling partner contains an 










Scheme 2.38: Proposed catalytic cycle of 1,4-Rh(III)-migration.
[50]
 
In summary, it has been highlighted that Rh, Ru and Pd-based catalysts can provide a 
range of complex molecules via oxidative annulation reactions of alkynes/1,3-enynes 
with various substrates possessing oxygen directing groups. The substrate scope 
ranges from commonly available starting materials such as carboxylic acids, benzylic 
alcohols, phenols or simply synthesised dicarbonyls. Based on described examples 
this approach is very versatile and can provide with the formation of either carbo- or 
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2.4 CONCLUSION  
Alkynes and 1,3-enynes are really important intermediates that have been employed 
in many oxidative C(sp
2
)–H functionalisation reactions with a variety of 
commercially available starting materials. The interest of this methodology is still 
high as the annulated carbocyclic and heterocylic products can be achieved in a 
simple and sustainable way. The possibility to run these reactions under low catalyst 
loading and under air has been already achieved but still opens up opportunities to 
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2.5 RESEARCH AND DISCUSSION  
Unless stated otherwise conversion and regioselectivity ratio were determined by 
1
H NMR 
analysis of the unpurified reaction mixtures. Yields are of pure isolated products.  
As previously reported by our group, 2-aryl 1,3-dicarbonyls were effective substrates 
in the oxidative annulation reaction with alkynes and provided a range of interesting 
carbocyclic spiroindene products (Scheme 2.39a).
[48],[49]
 The efficiency of the 
reaction was due to the enol moiety embedded within the 1,3-dicarbonyl, as it acted 
as a directing group for the C(sp
2
)–H bond functionalisation. At this stage, we 
wondered if 2-alkenylphenols, possessing a similar hydroxyl group, could serve as 
good coupling partners (Scheme 2.39d). During the course of our studies, the group 
of Luan and co-workers showed that 1-aryl-2-naphthols can undergo a dearomatising 
oxidative annulation reaction with alkynes under Ru-catalysis;
[43]
 however, the 
reaction conditions were not effective for phenol-derived substrates (Scheme 2.39b). 
Moreover, work from Gulias and Mascareñas employing 2-vinylphenols as directing 
groups in C–H functionalisation reactions provided the benzoxepine product, rather 
than the spirocylic enone (Scheme 2.39c).
[45]
 Having assessed the work of our group 
and others, we focused towards finding suitable conditions that would allow the 










Scheme 2.39: Enol-directed oxidative annulation of related substrates with alkynes.
[46]
 
2.5.1 SYNTHESIS OF VARIOUS SUBSTITUTED 2-ALKENYLPHENOLS 
Our investigation started with the synthesis of a range of various 2-alkenylphenols 
2.79. In general, most of these were obtained from a lithiation reaction of 2-(2-
bromophenoxy)-tetrahydro-2H-pyran 2.75 using n-BuLi to give aryl lithium 2.76. 
Addition of the appropriate ketone 2.77 then gave tertiary alcohols 2.78 which on 
dehydration using concentrated H2SO4 gave access to a range of 2-alkenylphenols 





THE UNIVERSITY of EDINBURGH 
 
 
Table 1.1 Synthesis of various 2-alkenylphenols. 
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The Witting reaction was employed for the synthesis of 2.79a
[54]
 and 2.79b giving 
83% and 30% yield, respectively (Scheme 2.40A). 2-Phenylvinyl phenol 2.79c was 
obtained by addition of Grignard reagent PhMgBr to 2`-hydroxyacetophenone 2.77 
followed by acid-catalysed dehydration (Scheme 2.40B). 
 
Scheme 2.40: Synthesis of various starting materials. 
2.5.2 CATALYTIC SYSTEM 
After the synthesis of starting materials, we focused on their application as potential 
coupling partners in oxidative annulation reactions with alkynes. Thus, the screening 
of potential catalyst systems began. As a model reaction we chose 2-vinylphenol 
2.79a and commercially available alkynes: diphenylacetylene 2.4a and 1-phenyl-1-
propyne 2.4b. Initial catalyst screening showed that the combination of [Cp
*
RhCl2]2 
catalyst and Cu(OAc)2 as an oxidant was a good choice. (Table 1.2, entries 1–2). 
However, the expected spirocyclic enone products 2.80a and 2.81a were not 
obtained. The NMR spectroscopic analysis showed the formation of benozoxepine 
products 2.82a and 2.83a instead, in 67% and 74% yield, respectively. Similar results 
were reported by Gulias and Mascareñas during the course of our research.
[45]
 
Further investigation of commonly used catalysts for oxidative annulation of alkynes 
such as [RuCl2(p-cymene)]2 and Pd(II) catalysts such as Pd(OAc)2, Pd2(dba)3, 
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than 10% conversions (entries 3 and 4), as a complex mixture of products (entry 5) 
or no product formation at all (entries 8 and 9). 




   R
2 
Catalyst Solvent Conversion (yield) 













2 Ph Ph [Cp
*
RhCl2]2 DMF 74 yield
a 
3 Me Me [RuCl2(p-cymene)]2 DMF <10
b 
4 Ph Ph [RuCl2(p-cymene)]2 DMF <10
b 
5 Ph Ph [RuCl2(p-cymene)]2 t-AmOH <5
c 
6 Ph Ph PEPPSI-IPr DMF  <5
b,f
 
7 Ph Ph Pd(OAc)2 DMF Complex 
 Mixture
d,f 










  Reaction conditions: 
a
Rh(III) (2.5 mol%); 
b
[M] (5 mol%); 
c
Ru(II) (2.5 mol%), K2CO3 (0.20 
mmol); 
d
Pd(II) (5.0 mol%); 
e
Pd(II) (10 mol%), 1,10-phenanthroline (20 mol%), NaOAc (5 
equiv.); 
f
Reaction conducted at 120 °C 
 
Next, the reaction of vinylphenol 2.79a and diphenylacetylene 2.4a catalysed by 
[Cp*RhCl2]2 was run in various solvents and at different temperatures: in toluene at 
60 °C, DCE at 90 °C and t-Am-OH at 90 °C. None of these reactions went to 
completion after stirring for 20 h. Lowering Cu(OAc)2 loading from 2.1 equivalents 
to 50 and 20 mol%  in DMF at 50 °C revealed a drop in conversion from 99% to 
75% and 64 %, respectively. 
The choice of substrate proved a major turning point in this project. When 
phenylvinyl phenol 2.79c and diphenylacetylene 2.4a were introduced into the 
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was the dearomatised spirocyclic enone 2.80c. As the yield of the reaction was only 
50%, our efforts were directed towards the optimisation of this process.  
As demonstrated by the group of Gulias and Mascareñas,
[45]
 running the reactions of 
2-vinylphenols in acetonitrile was necessary for the synthesis of benzoxepine 
products in high yield. These reaction conditions were next investigated for the 
formation of spirocyclic enone 2.80c. Gratifyingly, an improvement in yield was also 
noticed and reached 74% in comparison to the reaction run in DMF (Table 1.3, entry 
2). Due to the fact that rhodium metal abundance is low and the price of the catalyst 
is high, our efforts focused on lowering the catalyst loading and whilst retaining the 
high yield. Surprisingly, the reactivity of the reaction was the same and the final 
product 2.80c was obtained in 83% yield using just only 1 mol% of rhodium catalyst 
(Table 1.3, entry 3). We then examined the oxidant loading. It is possible to limit the 
stoichiometric by-products to water by running the reaction under catalytic amount 
of Cu(OAc)2 (5 mol%), [Cp*RhCl2]2 (1 mol%) and balloon of air (Table 1.3, entry 
6). Varying the loading of Cu(OAc)2 from sub- to super-stoichiometric, showed no 
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Table 1.3: Optimisation of spirocyclic enone product. 
 
















2 2.1 CH3CN 85  74
a 
3 0.5 CH3CN 85 83 
4 0.2 CH3CN 85 77 
5 0.1 CH3CN 85 77 
6 0.05 CH3CN 85 83 
 
            
a
Reaction conducted with 2.5 mol% of [Cp*RhCl2]2 
2.5.3 SUBSTRATE SCOPE: 
 Alkynes 
Next, the optimised conditions were applied to a range of 2-alkenylphenols 2.79c–h 
to provide access to various dearomatised spirocyclic compounds 2.80c–h (Scheme 
2.41). Gratifyingly, introduction of the substituents at the ortho-position of the non-
phenolic aromatic ring worked well, regardless of the electronic character of the 
substituent, and gave the final products 2.80d and 2.80e in high yields, 76% and 
84%, respectively. Similarly, incorporation of the substituents at the meta- or para-








Scheme 2.41: Synthesis of various spirocyclic enones with diphenylacetylene. 
When unsymmetrical alkyl/aryl-substituted-alkyne, 1-phenyl-1-propyne 2.4b, was 
tested in place of diphenylacetylene 2.4a under optimised reaction conditions, the 
expected spirotetraenone 2.81 was obtained in only moderate yield. Even the 
introduction of a slightly higher catalyst loading [Cp*RhCl2]2 (2.5 mol%) and 
Cu(OAc)2 (20 mol%) succeeded in 51% yield (Figure 2.1, compound 2.81a). As the 
reactivity of alkyl aryl alkynes in comparison to diaryl alkynes is significantly lower 
in this oxidative spiroannulation process, a longer reaction time is needed for the 
substrate consumption. However, at the same time decomposition of the product was 
observed due to the product`s thermal instability. This problem was overcome by 
using super-stoichometric Cu(OAc)2 (2.1 equivalents) at a lower temperature of 65 
°C (Scheme 1.3, compounds 2.81a and 2.81b). Furthermore, in all cases, only a 
single regioisomer was detected by NMR analysis of the crude reaction mixture. The 
X-ray analysis of the purified product also confirmed the structure. It is believed that 
in case of unsymmetrical alkynes the formation of spirocyclic enone as the only one 
regioisomer is due to the polarisation of the triple bond in alkyne by the aromatic 
substituent. The development of small, positive charge facilitates the C–C bond 
formation. As a result of that, rhodium is then attached to the carbon next to the 








Figure 2.1: Reactions of 2-(1-phenylvinyl)phenol with unsymmetrical alkynes. 
Finally, to further demonstrate the utility of our method, we applied our conditions to 
more challenging substrates: terminal 2.82a, dialkyl 2.82b, and protected alkynes 
2.82c and 2.82d. Unfortunately, a complex mixture of products was obtained in all 
cases, regardless of the reaction conditions employed (Figure 2.2). 
 
Figure 2.2: Screening of terminal, dialkyl and protected alkynes.  
 1,3-Enynes  
Having assessed the scope of alkynes tolerated for the oxidative spiroannulation 
process, our attention was focused next towards different coupling partners to further 
expand the scope of the reaction. In this context, 1,3-enynes were then examined. A 
number of these substrates were synthesised during a previous project within our 
laboratory by Dr David Burns and Martin Wieczysty. In general, they were obtained 
in a Sonogashira coupling between an arylalkenyl halide and terminal alkyne. 
However, some alkenyl bromides are not commercially available and it was required 









Scheme 2.42: Synthesis of 1,3-enynes using Sonogashira coupling procedures 
Alternatively, 1,3-enyne 1-(hex-1-ynyl)cyclohexyl-1-ene 2.85e was obtained using 





Scheme 2.43: Synthesis of 1,3-enyne 2.85e. 
1,3-Enynes were next examined under the optimised conditions for the oxidative 
annulation process. Pleasingly, all of the tested substrates provided the final 
spirocyclic enones 2.86a–k in high yields as a single regioisomer in the presence of 
super-stoichiometric Cu(OAc)2 at 65 °C (Scheme 2.44). It was observed that various 
substituents in the alkene component of the 1,3-enyne were tolerated. Compounds 
2.86a–e with p-methylstyryl, benzoate 2.86f–i, vinyl 2.86j, cyclohexenyl 2.86k 
groups all gave excellent yields with a range of electronically diverse 2-[1-
(hetero)arylvinyl]phenols 2.79. Furthermore, incorporation of a simple alkyl 2.86f–k, 
and oxygenated alkyl substituents 2.86a–c on the alkyne part of the 1,3-enyne was 
also tolerated as was an unprotected alcohol 2.86e. We also successfully screened 2-
(1-arylalkenyl)phenols  which contained various substituents at the non-phenolic ring 
at the ortho-position: 2-chloro 2.86b, 2-allyloxyl 2.86e, 2-methoxy 2.86g, 2-hydroxy 
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we also discovered that thienyl-containing substrates (2.86c and 2.86d) were also 
effective in providing good results, despite the possibility of poisoning the catalyst 
by sulfur coordination to the metal centre. All of the described reactions proceeded 
with >19:1 regioselectivity. The use of a catalytic amount of Cu(OAc)2 (5 mol%) 
under air was also investigated in this spiroannulation process with 1,3-enynes. The 
formation of a final product in lower 87% yield was observed in comparison to 97%, 
when superstiochiometric amount of Cu(OAc)2 was used 2.86f. 
 
Scheme 2.44: Synthesis of spirocyclic enones with various enynes. 
                                                                     a
Reaction time was 15 min; 
b
Reaction time was 30 min. 
        c
Reaction conducted with Cu(OAc)2 (5 mol%) under air at 85  
                                            °C for 5 h; 
d
Using 1.2 equiv. of enyne, 
e
Reaction conducted at 
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In addition, we have also shown that this methodology is not only limited for 
substrates containing a (hetero)aryl substituent at the 1-position of an alkene but the 
reaction of 2-alkenylphenol 2.79b with 1,3-enyne 2.85c also gave the dearomatised 
product 2.86l in 83% yield as shown in Scheme 2.45 below. 
 
Scheme 2.45: Synthesis of spirocyclic enone 2.86l from 2-alkenylphenol 2.79b. 
2.5.4  POSTULATED CATALYTIC CYCLE 
The postulated mechanism of the dearomatising oxidative spiroannulation of alkynes 
and 1,3-enynes with 2-alkenylphenols is shown below in Scheme 2.46 and follows 
the described mechanism for similar processes in the literature.
[45]
 First, the 
formation of an active catalyst rhodium(III) diacetate 2.14 occurs by ligand exchange 
with Cu(OAc)2, followed by the phenol-directed functionalisation of substrate 2.79 
to give the six-membered rhodacycle 2.87.  Then, coordination and migratory 
insertion of an alkyne generates the rhodacycle 2.88. When R
1
 = H, then a new C–O 
bond formation occurs via reductive elimination giving benzoxepine product 2.55. 
This postulated pathway has been reported previously by Gulias and Mascareñas.
[45]
 
However, in our studies, when R
1
 is not hydrogen, we believe that isomerisation of 
2.88 into rhodacyle 2.89 occurs because of steric interactions between R
1
 and the 
phenoxide ring. The final spiroenone product 2.80 is formed via C–C reductive 
elimination step releasing Rh(I) 2.17 catalyst which undergoes oxidation with 









Scheme 2.46: Proposed catalytic cycle.
[46],[47] 
Simultaneously, Gulias and Mascareñas published similar work in regards to alkyne 
oxidative annulation reactions with 2-alkenylphenols under rhodium catalysis. The 
scope revealed that symmetrical alkyl and aryl alkynes were tolerated in this 
reaction. In terms of unsymmetrical alkynes, only one regioisomer was observed by 
NMR spectroscopy and its structure was confirmed by X-ray analysis. The 
placement of a substituent at the internal position of an alkene, such as methyl, ethyl 
or phenyl was successful for the reaction outcome (2.80c, 2.80i–n). Changing the 
electronic character of a phenol ring, by introducing various functional groups, e.g. 









Scheme 2.47: Synthesis of spirocyclic enones under Rh-catalysed oxidative annulation of  
                        2-alkenyl phenols 2.79 by Gulias and Mascareñas. 
[47]
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2.5.5 PRODUCT UTILITY 
To demonstrate the utility of the oxidative spiroannulation methodology, 
manipulation of a spiroproduct was investigated. By treating product 2.80o, that 
contains an electrophilic dienone and a nucleophilc phenol, with Et3N resulted in the 
formation of the highly functionalised tetracycle 2.90. This 1,6-addition proceeds via 
the attack of the phenoxide onto the dienone. We also recovered 18% of the 
unreacted starting material (Scheme 2.48). 
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2.6 CONCLUSIONS AND FUTURE WORK  
We have developed the synthesis of highly complex spirocyclopentadienes in high 
yields via the oxidative annulation reaction between 2-alkenyl phenols and alkynes 
utilising a rhodium catalyst. The nature of the substitution on the alkenyl phenol was 
found to be incredibly important, small substituents led to the formation of a seven-
membered heterocyclic product, while bulkier groups in this position led to the 
intriguing spirocyclic product. 
 
Scheme 2.49: The divergent reactions of 2-alkenylphenols under rhodium catalysis. 
The resultant 1,6-enones could also be exploited by using a starting material that 
featured a nucleophilic moiety which could then undergo conjugate addition to give 
high functionalised tetracyclic products. 
 
Scheme 2.50: The formation for tetracyclic products. 
Recently numerous groups have developed enantioselective C–H functionalisation 
protocols
[5]
 and given that the spirocyclic products feature a stereocentre, we intend 
to investigate whether similar catalytic systems can be successfully applied to our 
methodology to generate the same products in a stereoselective manner. Similarly 
our group have exploited 1,3 enynes that feature cis allylic protons as both one-
carbon annulation partners and three-carbon annulation partners
[50]
 via a 1,4 Rh-
migration pathway and it may be possible to use this methodology along with 
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2.7 EXPERIMENTAL PART  
This project was done in the collaboration with two of my work colleagues Dr Daniel 
Best and Dr David Burns. The data presented in this section represents experiments 
performed by me in regards to this project.  
General information 
Unless specified otherwise, all reactions were carried out under an atmosphere of 
nitrogen using oven-dried glassware. Et2O and THF were dried and purified by 
passage through activated alumina columns using a solvent purification system. 
Unless specified otherwise, all other commercially available reagents and solvents 
were used as received. All petroleum ether used was 40–60 °C petroleum ether. Thin 
layer chromatography (TLC) was performed on Merck DF-Alufoilien 60F254 0.2 mm 
precoated plates. Compounds were visualised by exposure to UV light or by dipping 
the plates into solutions of potassium permanganate or vanillin followed by heating. 
Flash column chromatography was carried out using silica gel (Fisher Scientific 60 Å 
particle size 35–70 micron). Melting points were recorded on a Gallenkamp melting 
point apparatus and are uncorrected. The solvent of recrystallisation is reported in 
parentheses. Infra-red spectra were recorded on a Nicolet Avatar 360 FT instrument 
on the neat compound using an attenuated total reflection (ATR) accessory with a 
diamond crystal and a germanium sample plate. NMR spectra were acquired on 





C NMR spectra were referenced to external tetramethylsilane 
via the residual protonated solvent (
1
H) or the solvent itself (
13
C). All chemical shifts 
are reported in parts per million (ppm). For CDCl3, the shifts are referenced to 7.27 
ppm for 
1
H NMR spectroscopy and 77.0 ppm for 
13
C NMR spectroscopy. For 
(CD3)2CO, the shifts are referenced to 2.05 ppm for 
1
H NMR spectroscopy and 29.84 
ppm for 
13
C NMR spectroscopy. All 
19
F NMR spectra were proton-decoupled. High-
resolution mass spectra were recorded using electrospray ionisation (ESI) techniques 
at the School of Chemistry, University of Edinburgh, or at the School of Chemistry, 








General Procedure A: Synthesis of compounds 2.79a and 2.79b using a 
modification of Manabe`s procedure
[54]
 
To a solution of methyltriphenylphosphonium bromide in THF at 0 ºC was added n-
BuLi and the mixture was warmed to room temperature and then stirred at reflux for 
1 h. The reaction mixture was cooled to 0 ºC and the corresponding aldehyde or 
ketone was added. The vessel was allowed to warm to room temperature and stirred 
for 2.5 or 6 h. The reaction was then diluted with Et2O, washed with 1:1 brine/sat. 




The title compound was prepared according to the General Procedure A 
using methyltriphenylphosphonium bromide (10.11 g, 28.30 mmol), n-
BuLi (2.5 M in hexanes, 11.5 mL, 28.3 mmol) and salicylaldehyde (1.30 mL, 12.3 
mmol) for a reaction time of 2.5 h and was purified by flash chromatography (0 to 
20% EtOAc/hexane) to give 2.79a (1.32 g, 89%) as a colourless oil. Physical and 






The title compound was prepared according to the General Procedure A 
using methyltriphenylphosphonium bromide (3.93 g, 11.0 mmol), n-
BuLi (1.6 M in hexanes, 6.9 mL, 11 mmol) and 2’-hydroxyacteophenone (0.60 mL, 
5.0 mmol) for a reaction time of 6 h and was purified by flash chromatography (0 to 
10% EtoAc/petroleum ether) to give 2.79b (201 mg, 30%) as a colourless oil. 
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To a solution of 2’-hydroxyacetophenone 2.77 (3.6 mL, 30 mmol) in dry THF (50 
mL) at 0 ºC was added phenylmagnesium bromide (3.0 M in Et2O, 20 mL, 60 
mmol). The mixture was stirred at reflux for 24 h, cooled to 0 ºC and conc. H2SO4 
(2.0 mL, 38 mmol) was added over ca. 1 min with vigorous stirring. The mixture was 
stirred at 60 ºC for 16 h, cooled to room temperature, diluted with Et2O (100 mL), 
washed with 1:1 brine/sat. NaHCO3 (2 × 100 mL) and brine (50 mL), dried over 
MgSO4 and concentrated in vacuo. Purification of the residue by flash column 
chromatography (4 to 40% CH2Cl2/petroleum ether) gave 2.79c (4.78 g, 81%) as a 




General Procedure C: Preparation of Enynes 
 
To a solution of the appropriate alkenyl bromide (1 equiv.), Pd(PPh3)2Cl2 (1 mol%) 
and CuI (10 mol%) in Et3N was added the appropriate alkyne (1.1 equiv) and the 
mixture was stirred at 50 °C for 15 h. The reaction mixture was cooled to room 
temperature, diluted with Et2O (50 mL), washed with brine (50 mL), and the aqueous 
layer was further extracted with Et2O (2 × 50 mL). The organic layers were 
combined, dried with MgSO4 and concentrated in vacuo. Purification of the residue 








1-yl]oxy}silane (2.85a)  
The title compound was prepared according to General 
Procedure C using (E)-1-(2-bromovinyl)-4-methylbenzene
[56] 
(985 mg, 5.00 mmol), 
Pd(PPh3)2Cl2 (35 mg, 50 µmol) and CuI (95 mg, 0.50 mmol),  and 4-(tert-
butyldimethylsilyloxy)-1-butyne (1.01 g, 5.50 mmol) to give enyne 2.58a (1.24 g, 
82%) as an orange oil. Rf  0.74 (10% EtOAc/petroleum ether); IR 2953, 2928, 2857, 




H NMR (500 MHz, CDCl3) δ 7.27 
(2H, d, J = 8.0 Hz, 2 × ArH), 7.13 (2H, d, J = 8.0 Hz, 2 × ArH), 6.87 (1H, d, J = 16.2 
Hz, ArCH=CH), 6.10 (1H, dt, J = 16.2, 2.2 Hz, ArCH=CH), 3.80 (2H, t, J = 7.2 Hz, 
CH2O), 2.60 (2H, td, J = 7.2, 2.2 Hz, CH2CH2O), 2.35 (3H, s, ArCH3), 0.93 (9H, s, 
C(CH3)3), 0.11 (6H, s, 2 × SiCH3); 
13
C NMR (125.8 MHz, CDCl3) δ 140.4 (CH), 
138.3 (C), 133.7 (C), 129.3 (2 × CH), 126.0 (2 × CH), 107.5 (CH), 89.1 (C), 80.9 
(C),  62.0 (CH2), 25.9 (3 × CH3), 24.0 (CH2), 21.3 (CH3), 18.4 (C), −5.26 (CH3), 







The title compound was prepared according to a modification of 
General Procedure C (in that the vinyl bromide was used in excess (1.5 equiv.) and 
the chromatography eluent was petroleum ether) using vinyl bromide (1.0 M in 
hexanes, 11.5 mL, 11.5 mmol) and 4-phenyl-1-butyne (1.00 g, 7.70 mmol) to give 
enyne 2.85d (664 mg, 55%) as a yellow oil. Rf 0.50 (petroleum ether); IR 3028, 




H NMR (400 MHz, CDCl3) δ 7.35–7.28 (2H, m, 
ArH), 7.26–7.20 (3H, m, ArH), 5.79 (1H, ddt, J = 17.5, 11.0, 2.2 Hz, CH2=CH), 5.56 
(1H, ddd, J = 17.5, 2.2, 0.5 Hz, CHAHB=), 5.40 (1H, dd, J = 11.0, 2.2 Hz, CHAHB=), 
2.87 (2H, t, J = 7.4 Hz, CH2Ph), 2.60 (2H, td, J = 7.0, 2.2 Hz, CH2CH2Ph); 
13
C NMR 
(100.6 MHz, CDCl3) δ 140.6 (C), 128.42 (2 × CH), 128.36 (2 × CH), 126.3 (CH), 
125.8 (CH2), 117.5 (CH), 90.2 (C), 80.0 (C), 35.1 (CH2), 21.6 (CH2); HRMS (ESI 
+ve) Exact mass calculated for C12H13 [M+H]
+
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General Procedure D: Using Catalytic Copper 
 
A stirred solution of the appropriate 2-alkenylphenol (0.50 mmol), [Cp*RhCl2]2 (3.1 
mg, 5.0 µmol), Cu(OAc)2 (4.5 mg, 25 µmol) and the appropriate alkyne (0.60 mmol) 
in MeCN (2.0 mL) was heated at 85 °C under a balloon of air for the indicated time. 
The reaction mixture was cooled to room temperature, filtered through a short pad of 
silica using Et2O (25 mL) as the eluent and concentrated in vacuo. Purification of the 
residue by flash column chromatography gave 2.80, 2.81 or 2.86. 
General Procedure E: Using Stoichiometric Copper 
 
To a microwave vial, was added the appropriate 2-alkenylphenol (0.5 mmol), 
[Cp*RhCl2]2 (7.7 mg, 13 µmol), Cu(OAc)2 (191 mg, 1.05 mmol) and the appropriate 
alkyne (0.55 mmol). The vessel was then sealed and flushed with N2 and MeCN (3 
mL) was added. The reaction was then heated 65 °C for the indicated time. The 
reaction was cooled to room temperature, filtered through a short pad of silica using 
Et2O (25 mL) as eluent and concentrated in vacuo. Purification of the residue by 









The title compound was prepared according to General Procedure D 
from 2-alkenylphenol 2.79c (98 mg, 0.50 mmol) and 
diphenylacetylene 2.4a (107 mg, 0.60 mmol) for a reaction time of 90 min and was 
purified by flash column chromatography (0 to 10% EtOAc/petroleum ether) to give 
spirotetraenone 2.80c (155 mg, 83%) as a yellow foam. Rf 0.52 (20% 





NMR (400 MHz, CDCl3) δ 7.48 (1H, s, ArC=CH), 7.34–7.27 (6H, m, 6 × CH=), 
7.27–7.17 (7H, m, 7 × CH=), 7.14–7.08 (3H, m, 3 × CH=), 6.50 (1H, ddd, J = 9.2, 
6.0, 0.5 Hz, O=CCH=CHCH=CH), 6.30 (1H, d, J = 9.9 Hz, O=CCH=CHCH=CH), 
6.23 (1H, ddd, 9.2, 1.8, 0.9 Hz, O=CCH=CHCH=CH); 
13
C NMR (125.8 MHz, 
CDCl3  141.4 (CH), 134.8 
(C), 134.8 (C), 134.0 (CH), 133.5 (CH), 129.2 (2 × CH), 129.1 (CH), 128.7 (2 × 
CH), 128.4 (2 × CH), 128.2 (2 × CH), 128.0 (2 × CH), 127.60 (CH), 127.56 (CH), 
125.6 (2 × CH), 123.1 (CH), 99.7 (C), 75.3 (C); HRMS (ESI +ve) Exact mass 
calculated for C28H20NaO [M+Na]
+
: 395.1406, found: 395.1397; exact mass 
calculated for C28H21O [M+H]
+
: 373.1587, found: 373.1578. 
 
4-(2-Methoxyphenyl)-1,2-diphenylspiro[4.5]deca-1,3,7,9-tetraen-
6-one (2.80d)  
The title compound was prepared according to General Procedure D 
from 2-alkenylphenol 2.79d (113 mg, 0.50 mmol) and 
diphenylacetylene 2.4a (107 mg, 0.60 mmol) for a reaction time of 3.5 h and was 
purified by flash column chromatography (0 to 10% EtOAc/petroleum ether) to give 
spirotetraenone 2.80d (156 mg, 76%) as an orange foam. Rf 0.40 (20% 





NMR (400 MHz, CDCl3) δ 7.88 (1H, s, ArC=CH), 7.33–7.28 (2H, m, 2 × CH=), 
7.25–7.16 (7H, m, 7 × CH=), 7.14–7.10 (2H, m, 2 × CH=), 7.00 (1H, ddd, J = 9.8, 
6.0, 1.8 Hz, CH=), 6.94 (1H, dd, J = 8.3, 0.7 Hz, CH=), 6.84 (1H, td, J = 7.4, 1.1 Hz, 
CH=), 6.81 (1H, dd, J = 7.8, 1.9 Hz, CH=), 6.44 (1H, ddd,  J = 9.4, 6.1, 0.6 Hz, 
CH=), 6.27–6.21 (2H, m, 2 × CH=), 3.91 (3H, s, OCH3); 
13




THE UNIVERSITY of EDINBURGH 
 
 
CDCl3) δ 196.7 (C), 157.9 (C), 146.3 (C), 144.5 (C), 142.4 (CH), 141.8 (CH), 140.9 
(C), 138.7 (CH), 135.1 (C), 134.9 (C), 129.6 (2 × CH), 129.1 (CH), 128.5 (3 × CH), 
128.1 (CH), 128.0 (2 × CH), 127.8 (2 × CH), 127.4 (CH), 127.4 (CH), 122.8 (CH), 
122.6 (C), 120.6 (CH), 111.0 (CH), 76.9 (C), 55.1 (CH3); HRMS (ESI +ve) Exact 
mass calculated for C29H22NaO2 [M+Na]
+
: 425.1512, found: 425.1518; exact mass 
calculated for C29H23O2 [M+H]
+




The title compound was prepared according to General Procedure D 
from 2-alkenylphenol 2.79e (107 mg, 0.50 mmol) and 
diphenylacetylene 2.4a (107 mg, 0.60 mmol) at 85 °C for a reaction time of 4 h and 
was purified by flash column chromatography (0 to 10% EtOAc/petroleum ether) to 
give spirotetraenone 2.80e (164 mg, 84%) as a yellow foam. Rf 0.48 (20% 





NMR (400 MHz, CDCl3) δ 7.74 (1H, d, J = 1.9 Hz, ArC=CH), 7.33–7.27 (2H, m, 2 
× ArH), 7.26–7.14 (7H, m, 7 × ArH), 7.14–7.07 (3H, m, 3 × ArH), 7.06 (1H, ddd, J 
= 9.9, 6.0, 1.6 Hz, O=CCH=CHCH=CH), 7.03-6.99 (1H, m, ArC=CH), 6.81 (1H, td, 
J = 8.0, 1.6 Hz, CH=), 6.49 (1H, ddd, J = 9.2, 6.0, 0.4 Hz, O=CCH=CHCH=CH), 
6.27 (1H, d, J = 9.9 Hz, O=CCH=CHCH=CH), 6.22 (1H, ddd, J = 9.2, 1.6, 0.8 Hz, 
O=CCH=CHCH=CH); 
13
C NMR (100.6 MHz, CDCl3) δ 196.3 (C), 161.0 (d, J = 
252.5 Hz, C), 146.1 (d, J = 1.2 Hz, C), 142.8 (CH), 141.9 (d, J = 1.9 Hz, C), 141.8 
(d, J = 3.8 Hz, C), 141.0 (CH), 139.6 (d, J = 16.2 Hz, CH), 134.62 (C), 134.60 (C), 
129.4 (2 x CH), 129.1 (CH), 128.4 (2 x CH), 128.4 (d, J = 9.0 Hz, CH), 128.2 (2 x 
CH), 128.0 (d, J = 3.4 Hz, CH), 128.0 (2 x CH), 127.7 (CH), 127.6 (CH), 124.3 (d, J 
= 3.5 Hz, CH), 123.3 (CH), 121.7 (d, J = 11.4 Hz, C), 116.2 (d, J = 26.2 Hz, CH),  
76.3 (C); 
19
F NMR (376 MHz, CDCl3) δ –109.9 (s);  HRMS (ESI +ve) Exact mass 
calculated for C28H23FON [M+NH4]
+
: 408.1758, found: 408.1743; exact mass 
calculated for C28H19FNaO [M+Na]
+
: 413.1312, found: 413.1302; exact mass 
calculated for C28H20 FO [M+H]
+










The title compound was prepared according to General Procedure D 
from 2-alkenylphenol 2.79f (105 mg, 0.50 mmol) and 
diphenylacetylene 2.4a (107 mg, 0.60 mmol) for a reaction time of 3 h 
and was purified by flash column chromatography (0 to 10% EtOAc/petroleum 
ether) to give spirotetraenone 2.80f (138 mg, 71%) as a brown oil. Rf 0.52 (20% 





NMR (400 MHz, CDCl3) δ 7.44 (1H, s, ArC=CH), 7.33–7.26 (2H, m, 2 × CH=), 
7.25–7.13 (8H, m, 8 × CH=), 7.12–7.05 (3H, m, 3 × CH=), 7.05–7.00 (2H, m, 2 × 
CH=), 6.46 (1H, ddd, J = 9.1, 6.0, 0.5 Hz, O=CCH=CHCH=CH), 6.28 (1H, dt, J = 
9.7, 0.6 Hz, O=CCH=CHCH=CH), 6.20 (1H, ddd, J = 9.1, 1.8, 0.9 Hz, 
O=CCH=CHCH=CH), 2.29 (3H, s, CH3); 
13
C NMR (100.6 MHz, CDCl3) δ 196.4 
(C), 148.2 (C), 145.6 (C), 142.8 (CH), 141.9 (C), 141.5 (CH), 138.1 (CH), 134.9 (C), 
134.8 (C), 133.8 (C), 133.4 (C), 129.2 (2 × CH), 129.0 (CH), 128.6 (CH), 128.40 
(CH), 128.38 (2 x CH), 128.1 (2 × CH), 127.9 (2 × CH), 127.6 (CH), 127.5 (CH), 
126.3 (CH), 123.0 (CH), 122.7 (CH), 75.3 (C), 21.4 (CH3); HRMS (ESI +ve) Exact 
mass calculated for C29H22NaO [M+Na]
+
: 409.1563, found: 409.1565; exact mass 
calculated for C29H23O [M+H]
+




 The title compound was prepared according to General Procedure D 
from 2-alkenylphenol 2.79g (132 mg, 0.50 mmol) and 
diphenylacetylene 2.4a (107 mg, 0.60 mmol) for a reaction time of 4 h 
and was purified by flash column chromatography (0 to 10% EtOAc/petroleum 
ether) to give spirotetraenone 2.80g (169 mg, 77%) as a yellow solid. Rf 0.48 (20% 
EtOAc/petroleum ether); m.p. >152–154 °C (decomp.) (Et2O/petroleum ether); IR 




H NMR (400 MHz, CDCl3) δ 
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(2H, m, 2 × CH=), 7.31–7.19 (6H, m, 6 × CH=), 7.19–7.15 (3H, m, 3 × CH=), 6.59–
6.53 (1H, m, CH=), 6.35 (1H, d, J = 9.9 Hz, O=CCH=CHCH=CH), 6.25 (1H, ddd, J 
= 9.2, 1.7, 0.8 Hz, O=CCH=CHCH=CH); 
13
C NMR (100.6 MHz, CDCl3) δ 195.9 
(C), 146.4 (C), 145.4 (C), 143.2 (C), 143.0 (CH), 140.8 (CH), 135.7 (CH), 134.5 (C), 
134.4 (C), 134.1 (C), 131.0 (q, J = 32.8 Hz, C), 129.2 (CH), 129.1 (3 × CH), 128.5 
(CH), 128.4 (2 × CH), 128.2 (2 × CH), 128.0 (2 × CH), 127.8 (2 × CH), 123.9 (q, J = 
3.6 Hz, CH), 123.9 (q, J = 272.6 Hz, CF3), 123.5 (CH), 122.2 (q, J = 3.8 Hz, CH), 
75.1 (C); 
19
F NMR (376 MHz, CDCl3) δ –62.9 (s);  HRMS (ESI +ve) Exact mass 
calculated for C29H23F3NO [M+NH4]
+
: 458.1726, found: 458.1727; exact mass 
calculated for C29H19F3NaO [M+Na]
+
: 463.1280, found: 463.1280; exact mass 
calculated for C29H20 F3O [M+H]
+
: 441.1461, found: 441.1469.  
 
4-(4-Methylphenyl)-1,2-diphenylspiro[4.5]deca-1,3,7,9-tetraen-6-
one (2.80h).  
The title compound was prepared according to General Procedure D 
from 2-alkenylphenol 2.79h (105 mg, 0.50 mmol) and 
diphenylacetylene 2.4a (107 mg, 0.60 mmol) for a reaction time of 2 h 
and was purified by flash column chromatography (0 to 10% EtOAc/petroleum 
ether) to give spirotetraenone 2.80h (136 mg, 70%) as an orange foam. Rf 0.56 (20% 





(400 MHz, (CD3)2CO) δ 7.55 (1H, s, ArC=CH), 7.36–7.15 (H, m, 11 × CH=), 7.14–
7.07 (4H, m, 4 × CH=), 6.53 (1H, ddd, J = 9.2, 6.0, 0.4 Hz, O=CCH=CHCH=CH), 
6.22 (1H, ddd, J = 9.2, 1.8, 0.8 Hz, O=CCH=CHCH=CH), 6.17 (1H, d, J = 9.9 Hz, 
O=CCH=CHCH=CH), 2.28 (3H, s, CH3); 
13
C NMR (75.5 MHz, (CD3)2CO) δ 195.9 
(C), 149.6 (C), 146.2 (C), 143.7 (CH), 143.0 (C), 142.1 (CH), 138.0 (C), 136.2 (C), 
136.0 (C), 133.7 (2 × CH), 132.2 (C), 130.1 (3 × CH), 129.6 (CH), 129.2 (2 × CH), 
129.1 (2 × CH), 128.8 (2 × CH), 128.43 (CH), 128.36 (CH), 126.4 (2 × CH), 124.1 
(CH), 76.2 (C), 21.1 (CH3); HRMS (ESI +ve) Exact mass calculated for C29H23O 
[M+H]
+









Using catalytic copper: The title compound was prepared according 
to a modification of General Procedure D (in that the rhodium and 
copper loadings were increased) from 2-alkenylphenol 2.79c (98 mg, 0.50 mmol, 20 
mol%) and 1-phenyl-1-propyne 2.4b (70 mg, 0.60 mmol) at 85 °C for a reaction time 
of 3 h and was purified by flash column chromatography (0 to 10% 
EtOAc/petroleum ether) to give spirotetraenone 2.81a (78 mg, 51%) as an orange 
solid.  
Using stoichiometric copper: The title compound was prepared according to a 
modification of General Procedure E (in that 1.2 equiv of alkyne was used) from 2-
alkenylphenol 2.79c (98 mg, 0.50 mmol) and 1-phenyl-1-propyne 2.4b (70 mg, 0.60 
mmol) for a reaction time of 1 h and was purified by flash column chromatography 
(0 to 10% EtOAc/petroleum ether) to give spirotetraenone 2.81a (119 mg, 76%) as 
an orange solid. Rf 0.69 (50% EtOAc/petroleum ether); m.p. 122–124 °C 




H NMR (400 
MHz, CDCl3) δ 7.29–7.20 (7H, m, 7 × ArH), 7.19–7.11 (3H, m, 3 × ArH), 7.10 (1H, 
s, ArC=CH), 7.07 (1H, ddd, J = 9.8, 6.0, 1.9 Hz, O=CCH=CHCH=CH), 6.41 (1H, 
ddd, J = 9.2, 6.0, 0.5 Hz, O=CCH=CHCH=CH), 6.28 (1H, d, J = 9.8 Hz, 
O=CCH=CHCH=CH), 6.10 (1H, ddd, J = 9.2, 1.9, 0.8 Hz, O=CCH=CHCH=CH), 
2.03 (3H, s, CH3); 
13
C NMR (100.6 MHz, CDCl3) δ 196.9 (C), 147.5 (C), 143.0 
(CH), 143.0 (C), 142.2 (C), 142.1 (CH), 135.7 (CH), 134.5 (C), 133.4 (C), 128.9 
(CH), 128.8 (2 × CH), 128.5 (2 × CH), 127.8 (2 × CH), 127.3 (CH), 127.2 (CH), 
125.4 (2 × CH), 122.5 (CH), 74.4 (C), 14.1 (CH3); HRMS (ESI +ve) Exact mass 
calculated for C23H18NaO [M+Na]
+
: 333.1250, found: 333.1248; exact mass 
calculated for C23H19O [M+H]
+




The title compound was prepared according to a modification of 
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2.79c (98 mg, 0.50 mmol) and 1-phenyl-1-pentyne 2.4c (86 mg, 0.60 mmol) for a 
reaction time of 1 h and was purified by flash column chromatography (0 to 50% 
CH2Cl2/petroleum ether) to give spirotetraenone 2.81b (101 mg, 60%) as an orange 
solid. Rf 0.32 (50% CH2Cl2/petroleum ether); m.p. 98–100 °C (Et2O/petroleum 




H NMR (400 MHz, 
CDCl3) δ 7.32–7.23 (7H, m, 7 × CH=), 7.22–7.17 (2H, m, 2 × CH=), 7.16–7.10 (2H, 
m, 2 × CH=), 7.07 (1H, ddd, J = 9.8, 6.0, 1.9 Hz, O=CCH=CHCH=CH), 6.44 (1H, 
ddd, J = 9.1, 6.0, 0.7 Hz, O=CCH=CHCH=CH), 6.27 (1H, dt, J = 9.8, 0.7 Hz, 
O=CCH=CHCH=CH), 6.14 (1H, ddd, J = 9.1, 1.9, 0.7 Hz, O=CCH=CHCH=CH), 
2.41–2.25 (2H, m, CH2CH2CH3), 1.73–1.53 (2H, m, CH2CH3), 0.94 (3H, t, J = 7.4 
Hz, CH3); 
13
C NMR (100.6 MHz, CDCl3) δ 196.9 (C), 147.6 (C), 147.6 (C), 142.9 
(CH), 142.2 (C), 142.0 (CH), 134.5 (C), 133.9 (CH), 133.6 (C), 129.3 (2 × CH), 
128.9 (CH), 128.6 (2 × CH), 127.7 (2 × CH), 127.4 (CH), 127.2 (CH), 125.5 (2 × 
CH), 122.6 (CH), 74.8 (C), 29.8 (CH2), 22.4 (CH2), 13.8 (CH3); HRMS (ESI +ve) 
Exact mass calculated for C25H22NaO [M+Na]
+
: 361.1563, found: 361.1596; exact 
mass calculated for C25H23O [M+H]
+
: 393.1743, found: 339.1750.  
 
 Benzyl (E)-3-[2-butyl-4-methyl-10-oxospiro[4.5]deca-1,3,6,8-
tetraen-1-yl]prop-2-enoate (2.86j)  
The title compound was prepared according to General Procedure 
E from 2-alkenylphenol 2.79b (67 mg, 0.50 mmol) and enyne 
2.85c (133 mg, 0.55 mmol) for a reaction time of 20 min and was purified by flash 
column chromatography (0 to 10% EtOAc/petroleum ether) to give spirotetraenone 
2.86j (153 mg, 82%) as an orange oil. Rf 0.42 (20% EtOAc/petroleum ether); IR 




H NMR (400 MHz, 
CDCl3) δ 7.57 (1H, d, J = 15.7 Hz, BnO2CCH=CH), 7.38–7.35 (4H, m, 4 × CH=), 
7.34–7.25 (2H, m, 2 × CH=), 6.53 (1H, ddd, J = 9.0, 6.2, 0.5 Hz, 
O=CCH=CHCH=CH), 6.37–6.31 (2H, m, 2 × CH=), 5.80 (1H, ddd, J = 9.2, 1.8, 0.8 
Hz, O=CCH=CHCH=CH), 5.17 (1H, d, J = 12.6 Hz, OCHAHB), 5.15 (1H, d, J = 
15.7 Hz, BnO2CCH=CH), 5.14 (1H, d, J = 12.6 Hz, OCHAHB), 2.64–2.48 (2H, m, 




THE UNIVERSITY of EDINBURGH 
 
 
CH2CH2CH3), 1.43–1.32 (2H, m, CH2CH3), 0.94 (3H, t, J = 7.4 Hz, CH3); 
13
C NMR 
(100.6 MHz, CDCl3) δ 196.3 (C), 167.2 (C), 159.0 (C), 150.3 (C), 143.3 (CH), 142.1 
(CH), 138.4 (C), 136.3 (C), 135.1 (CH), 134.9 (CH), 128.4 (2 × CH), 128.2 (2 × 
CH), 128.1 (CH), 127.9 (CH), 122.7 (CH), 114.2 (CH), 73.1 (C), 65.8 (CH2), 31.2 
(CH2), 27.5 (CH2), 22.3 (CH2), 13.8 (CH3), 12.7 (CH3); HRMS (ESI +ve) Exact 
mass calculated for C25H26NaO3 [M+Na]
+
: 397.1774, found: 397.1772; exact mass 
calculated for C25H27O3 [M+H]
+




The title compound was prepared according to General Procedure 
E from 2-alkenylphenol 2.79b (98 mg, 0.50 mmol) and enyne 2.85d (86 mg, 0.55 
mmol) for a reaction time of 20 min and was purified by flash column 
chromatography (0 to 10% EtOAc/petroleum ether) to give spirotetraenone 2.86l 
(146 mg, 87%) as an orange oil. Rf 0.22 (10% EtOAc/petroleum ether); IR 3026, 




H NMR (400 MHz, 
(CD3)2CO) δ 7.42 (1H, d, J = 9.9, 6.1, 1.8 Hz, O=CCH=CHCH=CH), 7.35-7.14 
(11H, m, 11 × CH=), 6.55 (1H, J = 9.2, 6.1, 0.6 Hz, O=CCH=CHCH=CH), 6.45-
6.35 (2H, m, 2 × CH=), 5.94 (1H, ddd, J = 9.2, 1.8, 0.9 Hz, O=CCH=CHCH=CH), 
4.87 (1H, dd, J = 3.5, 0.7 Hz, CHAHB=), 4.83 (1H, dd, J = 9.6, 0.8 Hz, CHAHB=), 
2.99-2.89 (2H, m, CH2), 2.88-2.73 (2H, CH2); 
13
C NMR (100.6 MHz, (CD3)2CO) δ 
195.6 (C), 150.0 (C), 149.5 (C), 145.0 (CH), 143.5 (CH), 143.3 (C), 142.1 (C), 136.0 
(CH), 134.8 (C), 129.50 (CH), 129.47 (2 × CH), 129.3 (2 × CH), 129.1 (2 × CH), 
128.3 (CH), 128.2 (CH), 126.8 (CH), 126.2 (2 × CH), 122.9 (CH), 113.4 (CH2), 72.0 
(C), 36.0 (CH2), 30.2 (CH2); HRMS (ESI +ve) Exact mass calculated for C26H22NaO 
[M+Na]
+
: 373.1563, found: 373.1580; Exact mass calculated for C26H23O [M+H]
+
: 
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